fluorodeoxyglucose f18 has been researched along with Carcinoma, Hepatocellular in 334 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (0.30) | 18.7374 |
| 1990's | 15 (4.49) | 18.2507 |
| 2000's | 73 (21.86) | 29.6817 |
| 2010's | 175 (52.40) | 24.3611 |
| 2020's | 70 (20.96) | 2.80 |
| Authors | Studies |
|---|---|
| Gantumur, D; Kamioka, H; Li, Y; Mizoi, K; Ogihara, T; Tsushima, Y; Zhang, X; Zhu, M | 1 |
| Ince, V; Kutlu, R; Pasahan, R; Sahin, E; Sahin, TT; Yilmaz, S | 1 |
| Padma, S; Pavithran, P; Sarma, M; Somasundaram, VH; Sundaram, PS | 1 |
| Deng, Y; He, J; Li, Y; Wang, S; Wang, T | 2 |
| Balcı, NC; Çelebi, F; Görmez, A; Ilgun, AS; Tokat, Y | 1 |
| An, J; Jung, JH; Kim, HI; Kim, JS; Kim, SY; Kim, W; Oh, B; Oh, JH; Oh, M; Oh, YJ; Shim, JH; Sung, CO | 1 |
| Akuta, N; Arase, Y; Fujiyama, S; Hashimoto, M; Hosaka, T; Ikeda, K; Kawamura, Y; Kobayashi, M; Kumada, H; Matsumura, M; Muraishi, N; Okubo, S; Saitoh, S; Sezaki, H; Shindoh, J; Suzuki, F; Suzuki, Y | 1 |
| Jiao, J; Yang, T; Zhang, Y; Zou, MH; Zou, Q | 1 |
| Boudousq, V; Desmarets, G; Fidani, T; Goupil, J; Pouget, JP | 1 |
| Hong, HS; Hwang, SH; Kim, D; Kim, DY; Kim, GM; Lee, HW; Lee, M; Park, MA; Yun, M | 1 |
| Fu, R; Jin, G; Luo, S; Wang, Y; Yu, Z; Zhang, J | 1 |
| Alataş, Ö; Çapa Kaya, G; Derebek, E; Gülcü, A; Karahan Şen, NP; Özdoğan, Ö | 1 |
| Akutsu, N; Hirano, T; Ishigami, K; Kawakami, Y; Nakase, H; Numata, Y; Sasaki, S; Wagatsuma, K | 1 |
| Kesim, S; Ozguven, S | 1 |
| Adam, R; Allard, MA; Azoulay, D; Besson, FL; Cherqui, D; Ciacio, O; Ghidaglia, J; Golse, N; Gomez, L; Lewin, M; Pittau, G; Sa Cunha, A; Salloum, C; Sönmez, RE; Vibert, E | 1 |
| Buck, AK; Hartrampf, PE; Higuchi, T; Kosmala, A; Lindner, T; Michalski, K; Schirbel, A; Schlötelburg, W; Serfling, SE; Weich, A; Werner, RA | 1 |
| Choyke, PL; Chung, JY; Escorcia, FE; Hernandez, J; Jakhete, N; Jones, J; Kassin, M; Lindenberg, L; Maass-Moreno, R; Mena, E; Molitoris, JK; Monge, C; Rabiee, A; Saboury, B; Salerno, KE; Shih, J; Turkbey, B; Unger, KR; Wood, B | 1 |
| Dong, DH; Ji, G; Li, XH; Wei, JP; Yan, CY; Yang, XS | 1 |
| Dong, A; Wang, Y; Zhang, J | 1 |
| Chen, X; Deng, H; Huang, Y; Ou, L; Song, Y; Wang, Y; Zhou, Y | 1 |
| Hotchi, S; Iwanaga, N; Machida, M; Ogura, K; Okubo, H; Sugo, H; Tanaka, H; Watanobe, I | 1 |
| Shao, F; Xie, P | 1 |
| Fukui, A; Hatano, E; Takai, A; Uchida, Y; Yoh, T | 1 |
| Besson, FL; Durand, E; Golse, N; Pascale, A; Sebagh, M; Sivapathasundaram, A | 1 |
| Dasgupta, S; Kashyap, Y; Kote, R; Kumar, A; Mishra, A; Ravina, M; Reddy, M | 1 |
| Halanaik, D; Meenakshi, LA; Pottakkat, B; Rajaraman, V; Selvaraj, AJ | 1 |
| Mori, Y; Novruzov, E; Novruzov, F | 1 |
| Agrawal, A; Purandare, N; Puranik, A; Rangarajan, V; Shah, S; Suthar, RR | 1 |
| Lv, J; Shi, H; Yin, H; Yu, H | 1 |
| Chen, R; Hu, Y; Huang, G; Liu, J; Sun, H; Zhou, X | 1 |
| Inan, N; Sokmen, BK | 1 |
| Liu, J; Lu, S; Luan, X; Ma, G; Wang, G; Wang, R; Wang, Z; Xu, B; Xu, X; Zhang, J; Zhang, W | 1 |
| Lee, Z; Lu, ZR; Sexton, S; Xin, W | 1 |
| An, S; Huang, G; Kang, F; Liu, J; Wei, W | 1 |
| Huang, R; Liu, Y; Qi, M; Su, M | 1 |
| Basu, S; Chalikandy, A; Yadav, S | 1 |
| Chen, X; Guo, Z; Jakobsson, V; Lin, R; Miao, W; Wang, C; Wen, X; Wu, X; Yang, Y; Zang, J; Zhang, J; Zhao, T | 1 |
| Fan, W; Feng, GK; Li, XL; Mei, Y; Wang, F; Xiao, YT; Ye, JC; Zeng, MS; Zhang, WG; Zhou, C | 1 |
| Chisthi, MM | 1 |
| Chapiro, J; Pucar, D; Saperstein, L; Savic, LJ; Schobert, I | 1 |
| Bastiaannet, R; de Jong, HWAM; Lam, MGEH; Lodge, MA | 1 |
| Joechle, K; Marcal, LP; Mason, MC; Tran Cao, HS; Vauthey, JN; Wei, SH; Yedururi, S | 1 |
| Machado-Aranda, D | 1 |
| Huo, L; Wang, J; Wang, X; Yang, X; Zhao, H | 1 |
| Chen, J; Deivasigamani, A; Gao, H; Hui, KM; Kong, SN; Shi, M; Xia, H; Xie, T | 1 |
| Geist, BK; Hacker, M; Huo, L; Li, F; Li, X; Lin, J; Wang, J; Wang, X; Yang, X; Zhang, H; Zhao, H | 1 |
| Aikata, H; Akagi, M; Awai, K; Chayama, K; Fujino, H; Hiramatsu, A; Imamura, M; Kawaoka, T; Kobayashi, T; Kodama, K; Morio, K; Murakami, E; Nakahara, T; Nakamura, Y; Namba, M; Ohdan, H; Ohya, K; Tsuge, M; Uchikawa, S; Yamauchi, M | 1 |
| Aslan, N; Erhamamci, S | 1 |
| Chung, JI; Jeon, J; Jo, H; Kim, SY; Ko, HY; Lee, J; Lee, M; Yun, M | 1 |
| Braren, R; Heid, I; Hörl, M; Kaissis, GA; Lohöfer, FK; Munoz-Alvarez, KA; Paprottka, P; Rummeny, EJ; Schwaiger, M; Steiger, K; Weichert, W | 1 |
| Cai, M; Hong, S; Li, G; Shen, Y; Wang, F | 1 |
| Balcı, C; Çelebi, F; Cindil, E; Dogusoy, GB; Tokat, Y; Yaghouti, K | 1 |
| Aubuchon, S; Dahman, B; Deng, Y; Heuman, D; Hubert, J; John, BV; Konjeti, VR; Love, E; Singal, AG; Solomon, C; Sundaram, LT; Tatum, JL; Thomas, S | 1 |
| Lerut, J; Li, QY; Luo, FZ; Wang, S; Xu, X; Yang, Z; Zheng, SS; Zhuang, L | 1 |
| Amaddeo, G; Calderaro, J; Chalaye, J; Galletto Pregliasco, A; Itti, E; Kharrat, R; Kobeiter, H; Laurent, A; Legou, F; Luciani, A; Mulé, S; Regnault, H; Tacher, V; Tenenhaus, A | 1 |
| Sagir Kahraman, A | 1 |
| Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J | 1 |
| Ida, Y; Iguchi, M; Kitano, M; Maekita, T; Maeshima, S; Shimizu, R; Shingaki, N; Tamai, H; Terada, M | 1 |
| Akuta, N; Arase, Y; Fujiyama, S; Hashimoto, M; Hosaka, T; Ikeda, K; Iritani, S; Kajiwara, A; Kawamura, Y; Kobayashi, M; Kobayashi, Y; Kumada, H; Muraishi, N; Okubo, S; Saitoh, S; Sezaki, H; Shindoh, J; Suzuki, F; Suzuki, Y; Yamashige, D | 1 |
| Choi, SY; Ha, SY; Hwang, JA; Hyun, SH; Kim, HS; Kim, SH; Kim, SW; Min, JH | 1 |
| Guniganti, P; Kierans, AS | 1 |
| Hu, C; Jin, H; Zhang, M | 1 |
| Lv, J; Mao, W; Shi, H; Yin, H | 1 |
| Graham, RP; Kendi, AT; Venkatesh, SK; Young, JR | 1 |
| Bom, HS; Cho, SG; Jeon, S; Kang, SR; Kim, DY; Kim, GJ; Kim, J; Kwon, SY; Lee, C; Min, JJ; Pyo, A; Song, HC; Yoo, SW | 1 |
| Abouzied, MM; Al Qahtani, M; Al Sugair, AS; Alhinti, N; AlMuhaideb, A | 1 |
| Freesmeyer, M; Malessa, C; Rauchfuss, F; Rudakoff, W; Settmacher, U; Winkens, T | 1 |
| Miao, W; Nie, P; Rao, W; Wang, Y; Wang, Z; Wu, F; Yan, L; Yang, G; Yu, M; Yu, T; Zhao, Y | 1 |
| Chen, FH; Chung, YH; Hong, JH; Lin, G; Tsai, CK; Wang, WL; Yang, CL; Yen, TC; Yu, CF | 1 |
| Ding, H; Geist, BK; Hacker, M; Huo, L; Li, F; Li, X; Liu, B; Shao, Y; Wang, J; Wang, X; Zhang, H; Zhao, H | 1 |
| He, J; Li, B; Li, P; Shi, H; Wang, Q; Wang, S; Xie, R | 1 |
| Akuta, N; Arase, Y; Fujiyama, S; Hashimoto, M; Hosaka, T; Ikeda, K; Iritani, S; Kawamura, Y; Kobayashi, M; Kobayashi, Y; Kumada, H; Muraishi, N; Okubo, S; Saitoh, S; Sezaki, H; Shindoh, J; Suzuki, F; Suzuki, Y | 1 |
| Kim, K; Kim, SJ | 1 |
| Li, W; Shakir, TM; Wang, Z; Zhao, Y | 1 |
| Fukumitsu, K; Hamaguchi, Y; Hata, K; Ishii, T; Kaido, T; Nakamoto, Y; Ogiso, S; Seo, S; Taura, K; Uemoto, S; Yoh, T | 1 |
| Hacker, M; Haug, A; Kaczirek, K; Li, S; Mitterhauser, M; Nanoff, C; Peck-Radosavljevic, M; Pinter, M; Rainer, E; Ubl, P; Wadsak, W; Wang, H | 1 |
| Geng, L; Wang, T; Wang, W; Yan, S; Ye, YF; Yu, J; Yu, SF; Zheng, SS | 1 |
| Beiderwellen, K; Deuschl, C; Forsting, M; Grüneisen, J; Herrmann, K; Heusch, P; Kirchner, J; Lauenstein, TC; Sawicki, LM; Umutlu, L | 1 |
| Cho, A; Hwang, SH; Kim, D; Kim, HJ; Lee, JW; Yun, M | 1 |
| Francis, R; Hardy, LE; Hessamodini, H; Wallace, M | 1 |
| Fu, T; Gao, Y; Kang, F; Li, G; Ma, W; Ma, X; Wang, J; Wang, S; Wang, Z; Yang, W; Zhao, M | 1 |
| Agarwal, KK; Mayank, M; Shah, D; Shah, N | 1 |
| Ceyhan, GO; Friess, H; Kornberg, A; Kornberg, J; Mueller, K; Schernhammer, M; Thrum, K; Witt, U | 1 |
| Kim, DY; Kwon, SY; Lee, C; Min, JJ; Yoo, SW | 1 |
| Bae, SH; Choi, JY; Hwang, S; Jang, JW; Park, HL; Song, MJ; Sung, PS; Yang, K; Yoo, IR; Yoon, SK | 1 |
| Chung, YA; Eo, JS; Hong, IK; Hyun, SH; Kim, TS; Lee, JW; Na, SJ; Oh, JK; Song, BI; Yun, M | 1 |
| Hatano, E; Higashi, T; Ishii, T; Kaido, T; Kawai, T; Nakamoto, Y; Ogiso, S; Okuda, Y; Seo, S; Taura, K; Uemoto, S; Yoh, T | 1 |
| Allaire, M; Amaddeo, G; Azoulay, D; Baranes, L; Calderaro, J; Chalaye, J; Costentin, CE; Duvoux, C; Ganne-Carrié, N; Itti, E; Luciani, A; Mallat, A; Nahon, P; Nault, JC; Seror, O; Soussan, M | 1 |
| Hu, Y; Liu, Y; Shi, H | 1 |
| Fan, G; Guo, J; Hao, S; Sun, M; Wang, Z; Zhang, G | 1 |
| Dong, A; Wang, Y; Zhong, X | 1 |
| Li, Q; Li, Y; Liao, S; Liao, X; Liu, Z; Wei, C; Wei, J; Zhong, J | 1 |
| Kang, SH; Kim, HB; Kim, SK; Kim, TS; Park, JW; Park, S | 1 |
| Hu, Y; Luo, R; Shi, H; Xiu, Y; Yin, H | 1 |
| Seo, S; Yoh, T | 1 |
| Bozkurtlar, E; Celikel, CA; Erdil, TY; Inanir, S; Oksuzoglu, K; Ones, T; Ozguven, S; Turoglu, HT | 1 |
| Mahadevan, P; Pratap, T; Ramesh, H; Senthil, R; Visakh R, A | 1 |
| Azoulay, D; Chalaye, J; Costentin, CE; Feray, C; Itti, E; Lahat, E; Lim, C; Osseis, M; Salloum, C | 1 |
| Ko, H; Lee, M; Yun, M | 1 |
| Chen, Y; Fang, C; Liu, H; Zhang, W | 1 |
| Cheng, Z; Song, S; Zhu, D; Zhu, X; Zou, S | 1 |
| Behr, SC; Flavell, RR; Kelley, RK; Perez, PM; Umetsu, S | 1 |
| Dong, M; Yang, J; Zhang, J; Zhu, Y | 1 |
| Gabata, T; Inoue, D; Kitao, A; Kobayashi, S; Koda, W; Kozaka, K; Matsui, O; Minami, T; Yoneda, N; Yoshida, K | 1 |
| Abuqbeitah, M; Akgün, E; Akovali, B; Asa, S; Demir, M; Gülsen, F; Sager, S; Sahin, O; Sayman, H; Sönmezoglu, K; Uslu-Beşli, L; Yeyin, N | 1 |
| Kim, HS; Lee, JW; Lee, S; Lee, SM | 1 |
| Shi, H; Tan, H; Wu, B; Zhang, Y | 1 |
| Cho, YS; Choi, JY; Hyun, SH; Lee, KH; Lim, CH; Moon, SH | 1 |
| Chen, FH; Chiu, H; Chiu, SC; Chung, YH; Hong, JH; Hsu, ST; Wu, CR; Yang, CL; Yen, TC; Yu, CF | 1 |
| Hausauer, B; Islam, Z; Keshavamurthy, J; Pucar, D | 1 |
| Chan, YC; Chen, CL; Cheng, YF; Elsarawy, AM; Hsu, CC; Kuo, FY; Li, WF; Lin, CC; Lin, LM; Lin, TL; Ling, LL; Wang, CC; Yong, CC | 1 |
| Bae, SH; Choi, JI; Choi, JY; Chun, HJ; Kim, HY; Lee, HG; Lee, SW; Lee, YJ; Song, DS; Song, MJ; Yoo, IeR; Yoon, SK | 1 |
| Dong, A; Dong, H; Zuo, C | 1 |
| Ishii, K; Kuroda, H; Matsuki, M; Murakami, T; Okada, M; Tsurusaki, M | 1 |
| Freesmeyer, M; Lopatta, E; Marlowe, RJ; Opfermann, T; Schierz, JH; Settmacher, U; Stallmach, A; Steenbeck, J | 1 |
| Farrell, EV; Haase, A; Janich, MA; Khegai, O; Menzel, MI; Nekolla, S; Otto, AM; Schulte, RF; Schwaiger, M; Wiesinger, F | 1 |
| Chen, D; Chen, ZF; Hu, AB; Wang, XY; Zhang, XS | 1 |
| Pant, V; Sen, IB; Soin, AS | 1 |
| Alavi, A; Basu, S; Kwee, TC; Lam, MG | 1 |
| Chan, SC; Chen, S; Cheung, TT; Fan, ST; Ho, CL; Lo, CM; Poon, RT | 1 |
| Ahn, SG; Cho, HJ; Jeon, TJ; Kim, KS; Kim, SH; Lee, JD; Lee, SD; Park, SJ; Park, YN; Yun, M | 1 |
| Ahn, SJ; Kang, WJ; Kim, I; Kim, KA; Kim, MJ; Lee, SK; Park, JY; Park, MS | 1 |
| Chang, LP; Chao, HL; Chen, CM; Chiu, CH; Huang, WS; Huang, WY; Jen, YM; Kao, CH; Lee, MS; Lo, CH | 1 |
| Dong, A; Dong, H; Wang, Y; Yu, H; Zuo, C | 1 |
| Fujihara, S; Izuishi, K; Kameyama, R; Masaki, T; Mori, H; Suzuki, Y; Yamamoto, Y | 1 |
| Dutta, J; Leahy, RM; Li, Q | 1 |
| Hatano, E; Hayakawa, N; Higashi, T; Nakamoto, Y; Nakatani, K; Saga, T; Seo, S; Togashi, K; Uemoto, S | 1 |
| Abe, K; Aishima, S; Ikeda, T; Ikegami, T; Kimura, K; Maehara, Y; Shirabe, K; Toshima, T; Yamashita, Y; Yoshizumi, T | 1 |
| Chang, JS; Choi, SH; Jeong, YH; Lee, Y; Seong, J; Yun, M | 1 |
| Endo, K; Hatano, E; Higashi, T; Kagawa, S; Kishibe, Y; Kitamura, K; Matsumura, K; Nishii, R; Seo, S; Takahashi, M; Takemoto, K; Tanabe, K; Taura, K; Toriguchi, K; Uemoto, S; Yamauchi, H; Zaima, M | 1 |
| Enomoto, M; Fujii, H; Hagihara, A; Iwai, S; Kawabe, J; Kawada, N; Kawamura, E; Kotani, K; Morikawa, H; Murakami, Y; Shiomi, S; Tamori, A; Uchida-Kobayashi, S | 1 |
| Cheng, X; Cui, R; Dang, Y; Huo, L; Li, F; Lü, J; Mao, Y; Xing, H | 1 |
| Bie, P; Huan, H; Lau, WY; Li, G; Ma, K; Qian, C; Wu, L; Xia, F | 1 |
| Ahmadzadehfar, H; Biersack, HJ; Bruhman, J; Ezziddin, S; Meyer, C; Pieper, CC; Sabet, A; Wasmuth, JC | 1 |
| Abrantes, AM; Botelho, MF; Brito, AF; Mendes, M; Tralhão, JG | 1 |
| Bai, M; Bai, W; Fan, D; Han, G; Jia, J; Ma, W; Quan, Z; Wang, J; Wang, S; Yi, J; Yin, Z | 1 |
| Jeng, LB; Kao, CH; Lin, WY; Lin, Y; Tsai, SC; Wang, HY | 1 |
| Alavi, A; Chauhan, MS; Hess, S; Jacob, MJ; Ravina, M | 1 |
| Chang, Z; Duan, F; Liu, F; Song, P; Wang, M; Wang, Y; Wang, Z | 1 |
| Aishima, S; Baba, S; Kubo, Y; Maehara, Y; Mano, Y; Motomura, T; Oda, Y; Shirabe, K; Tanaka, Y; Toshima, T | 1 |
| Cho, Y; Cho, YY; Choi, WM; Chung, JK; Kang, KW; Kim, YJ; Lee, DH; Lee, HS; Lee, JH; Lee, M; Lee, YB; Paeng, JC; Yoo, JJ; Yoon, JH; Yu, SJ | 1 |
| Heo, NY; Joo, YD; Kim, IH; Kim, JY; Kim, SH; Lee, SI; Park, JI; Park, SH; Shim, HK | 1 |
| Ahn, SY; Cheon, GJ; Choi, BI; Han, JK; Joo, I; Lee, ES; Lee, JM; Lee, SJ | 1 |
| Chan, PC; Chang, CA; Chang, CW; Chen, FD; Chiou, SH; Chou, LS; Ho, CH; Hwang, JJ; Lin, WJ; Liu, RS; Wang, HE; Wu, CY | 1 |
| Jeon, TJ; Kang, JH; Kim, KI; Kim, KM; Ko, YO; Lee, TS; Lee, YJ; Lim, SM; Nahm, SS; Park, JA; Park, JH; Park, YS; Yu, DY | 1 |
| Wang, X; Xu, Z; Zhang, L; Zhang, X | 1 |
| Cheng, JY; Fu, Y; Hu, SL; Song, HJ; Zhang, GY; Zhang, YJ | 1 |
| Choi, HJ; Kang, WJ; Kim, GM; Kim, JH; Seo, HJ | 1 |
| Ji, YH; Li, HS; Lv, L; Tian, Y; Wang, QS; Wang, SB; Wu, HB; Zhou, WL | 1 |
| Ahn, BC; Jeong, SY; Kim, DH; Lee, J; Lee, SW | 1 |
| Cho, YH; Choi, GS; Choi, HJ; Choi, MH; Chung, JC; Jang, JY; Jeong, SW; Jin, SJ; Kim, BS; Kim, DC; Kim, HS; Kim, SG; Kim, YS; Lee, MH; Lee, SH; Lee, YN; Moon, JH; Park, JM; Song, JY | 1 |
| Friess, H; Kornberg, A; Kornberg, J; Thrum, K; Witt, U | 1 |
| Asman, Y; Even-Sapir, E; Evenson, AR; Shibolet, O | 1 |
| Cho, A; Han, KH; Kim, DY; Lee, JD; Lee, JW; Lee, SM; Yun, M | 1 |
| Adachi, S; Akagi, K; Dono, K; Hatano, H; Imamura, H; Iwazawa, T; Komori, T; Masuike, Y; Morita, S; Noda, T; Oshima, K; Tanida, T; Yasumoto, T | 1 |
| Bletard, N; Delwaide, J; Deroover, A; Detry, O; Govaerts, L; Honoré, P; Hustinx, R; Lamproye, A; Malenga, S; Mbendi, C; Meunier, P; Meurisse, N; Vandermeulen, M | 1 |
| Baxa, J; Daum, O; Ferda, J; Ferdová, E; Kreuzberg, B; Skalický, T; Třeška, V | 1 |
| Hong, SK; Kim, SH; Kim, YK; Lee, SD; Park, SJ | 1 |
| Kim, SH; Kim, SK; Kim, YK; Lee, SD; Park, SJ | 1 |
| Fletcher, J; Maluccio, M; McCarthy, BP; Riley, AA; Saxena, R; Skill, NJ; Tann, M; Territo, PR | 1 |
| Cho, YH; Choi, DL; Jang, HY; Jang, JY; Jeong, SW; Kim, BS; Kim, HS; Kim, MJ; Kim, SG; Kim, YS; Lee, JM; Lee, MH; Lee, SH; Lee, WH; Park, JM; Song, JY | 1 |
| Cho, E; Choi, SK; Choi, WS; Jun, CH; Kim, BS; Son, DJ | 1 |
| Akcan, AB; Şahin, E | 1 |
| Gu, T; Jiang, L; Liu, F; Luan, L; Shi, H | 1 |
| Aishima, S; Maehara, Y; Shirabe, K; Yamashita, Y | 1 |
| Jiang, L; Panje, CM; Shi, H; Tan, H; Xiu, Y; Yu, H | 1 |
| Chung, YA; Ham, HJ; Jang, KS; Jung, YJ; Lee, J; Lee, JH; Maeng, LS; Park, MS; Park, SI | 1 |
| Capel, A; Cascales-Campos, PA; Frutos, L; Gonzalez, R; Llacer, E; Lopez, V; Muñoz-Ramon, P; Navarro, JL; Parrilla, P; Pons, JA; Ramírez, P; Robles, R; Saenz-Mateos, L; Sánchez Bueno, F | 1 |
| Bailly, M; Orain, I; Ribeiro, MJ; Salamé, E; Venel, Y | 1 |
| Agostini, H; Castilla-Lièvre, MA; Désarnaud, S; Franco, D; Gervais, P; Helal, BO; Kuhnast, B; Marthey, L | 1 |
| Choi, Y; Hong, G; Kim, H; Lee, KW; Paeng, JC; Park, MS; Suh, KS; Suh, SW; Yi, NJ; Yoo, T | 1 |
| Chung, YA; Eo, JS; Hong, IK; Hyun, SH; Kim, DY; Kim, SU; Kim, TS; Lee, JD; Lee, JW; Moon, DH; Na, SJ; Oh, JK; Song, BI; Yun, M | 1 |
| Cillo, U; Crivellari, G; Giuliani, T; Herrero Manley, LM; Polacco, M; Vitale, A | 1 |
| Hwang, SH; Kim, CK; Lee, M; Lee, N; Park, MA; Park, S; Yun, M | 1 |
| Dauer, LT; Gao, Y; Khong, PL; Liu, D; Mahmood, U; Quinn, B; St Germain, J; Xu, XG | 1 |
| An, L; Li, TF; Lv, GY; Mu, L; Shi, XJ; Sun, DW; Wang, CL; Wei, F; Zhao, ZW | 1 |
| Azoulay, D; Baranes, L; Boussouar, S; Calderaro, J; Chalaye, J; Chiaradia, M; Costentin, C; Decaens, T; Duvoux, C; Evangelista, E; Itti, E; Laurent, A; Lin, SJ; Luciani, A; Pigneur, F; Rahmouni, A | 1 |
| Cheng, W; Jing, H; Li, Y; Shao, H; Yu, L | 1 |
| Cheng, Z; Hu, N; Luo, J; Tan, Y; Wang, Y | 1 |
| Choi, JY; Chung, YA; Eo, JS; Hong, IK; Hyun, SH; Kim, KS; Kim, TS; Lee, JW; Lee, KH; Moon, DH; Na, SJ; Oh, JK; Song, BI; Yun, M | 1 |
| Abrantes, AM; Botelho, MF; Brito, AF; Casalta-Lopes, JE; Gonçalves, AC; Laranjo, M; Mamede, AC; Ribeiro, M; Sarmento-Ribeiro, AB; Tralhão, JG | 1 |
| Fujimoto, Y; Hatano, E; Kaido, T; Mizumoto, M; Mori, A; Nitta, T; Okajima, H; Seo, S; Taura, K; Uemoto, S; Wu, TH; Yamanaka, K; Yasuchika, K | 1 |
| Cheon, GJ; Chung, JK; Kang, KW; Kim, YI; Lee, DS; Paeng, JC; Suh, KS | 1 |
| Chan, YC; Chen, CL; Cheng, YF; Eng, HL; Hsu, CC; Lee, WF; Lin, CC; Lin, TL; Lin, YH; Liu, YW; Wang, CC; Wang, SH; Wu, YJ; Yong, CC | 1 |
| Chotipanich, C; Kunawudhi, A; Promteangtrong, C; Sricharunrat, T; Tungsuppawattanakit, P; Wongsa, P | 1 |
| Alauddin, Z; Fatima, N; Masood, M; Mirza, ZR; Qureshi, A; Shahid, A | 1 |
| Han, KH; Hwang, SH; Kim, DY; Lee, JW; Yun, M | 1 |
| Cho, HJ; Choi, GH; Hwang, SH; Kim, KS; Lee, JW; Yun, M | 1 |
| Byun, HK; Han, KH; Hwang, SH; Rhee, WJ; Seong, J; Yun, M | 1 |
| Akamatsu, N; Egawa, H; Endo, I; Furukawa, H; Gotoh, M; Hakamada, K; Honda, M; Inomata, Y; Ishiyama, K; Ito, E; Kaido, T; Kawagishi, N; Kenjo, A; Kokudo, N; Ku, Y; Kubo, S; Kuramitsu, K; Maehara, Y; Miyazaki, M; Nagano, H; Nakanishi, C; Ohdan, H; Ohtsuka, M; Okajima, H; Shirabe, K; Sugawara, Y; Takada, T; Takada, Y; Takahara, T; Takamura, H; Takeda, K; Taketomi, A; Toyoki, Y; Uemoto, S; Wada, H; Wakabayashi, G; Yamaue, H | 1 |
| Ahn, BC; Hong, CM; Jang, YJ; Jeong, SY; Lee, J; Lee, SW | 1 |
| Abuodeh, Y; Ahmed, KA; Anaya, DA; Biebel, B; Choi, J; El-Haddad, G; Frakes, JM; Hoffe, SE; Kim, R; Kim, Y; Kis, B; Malafa, M; Naghavi, AO; Sweeney, J; Venkat, PS | 1 |
| Chu, LY; Hsu, CN; Jeng, LB; Kao, CH; Liao, CW; Lin, CL; Lin, CY; Yen, KY | 1 |
| Acuff, S; Fu, Y; Kaman, A; Neveu, M; Osborne, DR; Syed, M | 1 |
| Ahn, CS; Hwang, S; Jung, DH; Kang, WH; Kim, KH; Lee, SG; Lee, YJ; Moon, DB; Park, GC; Song, GW | 1 |
| Abaalkhail, F; Ahmed, B; Al Sebayel, M; Al-Hamoudi, W; Al-Kattan, W; Alabbad, S; Alotaibi, F; Alsofayan, M; Boehnert, MU; Broering, D; Chorley, A; Elbeshbeshy, H; Elsiesy, H; Kabbani, M | 1 |
| Guo, QY; He, YX | 1 |
| Brouwers, AH; Hospers, GA; Mulder, NH; Siemerink, EJ | 1 |
| Deguchi, A; Kaji, M; Kameyama, R; Kashiwagi, H; Nishiyama, Y; Ohkawa, M; Okano, K; Yamamoto, Y | 1 |
| Galanski, M; Knapp, WH; Rodt, T; Shin, HO; von Falck, C | 1 |
| Endo, K; Nakajima, T; Oriuchi, N; Paudyal, B; Paudyal, P; Tsushima, Y | 1 |
| Chow, PK; Jin, Y; Ong, LC; Song, IC; Yu, S; Zhang, K | 1 |
| Choi, JI; Kang, KW; Kim, CM; Kim, JH; Kim, SK; Lee, WJ; Nam, BH; Park, JW; Park, KW | 1 |
| Chen, YL; Hung, GU; Lee, JK; Yeh, YH | 1 |
| Kuang, Y; Lee, Z; Maclennan, GT; Salem, N; Wang, F | 1 |
| Eisele, RM; Neuhaus, P; Schumacher, G | 1 |
| Bärthel, E; Freesmeyer, M; Gottschild, D; Habrecht, O; Jandt, K; Katenkamp, K; Kornberg, A; Sappler, A; Settmacher, U; Steenbeck, J | 1 |
| Huang, YC; Lin, HC; Tung, CL | 1 |
| Hatano, E; Higashi, T; Ikai, I; Iwaisako, K; Kitamura, K; Nakajima, A; Nakamoto, Y; Seo, S; Tada, M; Tamaki, N; Uemoto, S | 1 |
| Chung, JK; Kang, KW; Kwon, HW; Lee, DS; Lee, JW; Lee, MC; Paeng, JC; Suh, KS | 1 |
| Dierckx, R; Maes, A; Peeters, M; Van De Wiele, C | 1 |
| Bang, SH; Kim, JW; Kim, KS; Lee, JD; Park, JY; Yun, M | 1 |
| Ahn, KJ; Bang, SH; Hwang, HS; Kang, WJ; Lee, JD; Park, JH; Yun, M | 1 |
| Bender, H; Biersack, HJ; Bucerius, J; Fischer, HP; Pauleit, D; Rabe, C; Risse, JH | 1 |
| Hatano, E; Higashi, T; Ikai, I; Ishizu, K; Kamimoto, S; Kawashima, H; Kitamura, K; Nakamoto, Y; Nishii, R; Seo, S; Suga, T; Takada, Y; Togashi, K; Uemoto, S | 1 |
| Bako, F; Banfalvi, G; Hunyadi, J; Juhasz, T; Kertai, P; Marian, T; Pocsi, I; Trencsenyi, G | 1 |
| Lencioni, R; Llovet, JM | 1 |
| Li, J; Liu, Y; Wang, JW; Xu, LM; Zhao, S | 1 |
| Cho, SY; Han, SS; Kim, SH; Kim, SK; Kim, YK; Lee, KW; Park, SJ | 1 |
| Dittmar, Y; Götz, M; Heise, M; Rauchfuss, F; Scheuerlein, H; Settmacher, U; Voigt, R | 1 |
| Bang, YJ; Han, SW; Im, SA; Kim, TY; Oh, DY; Shin, DY | 1 |
| Ancel, D; Balogova, S; Fartoux, L; Grange, JD; Gutman, F; Huchet, V; Kerrou, K; Nataf, V; Rosmorduc, O; Talbot, JN | 1 |
| Chen, S; Cheng, TK; Ho, CL; Leung, YL | 1 |
| Kim, HO; Kim, JS; Lee, SG; Lee, YS; Ryu, JS; Shin, YM | 1 |
| Corn, DJ; Kolthammer, JA; Kuang, Y; Lee, Z; Salem, N; Tian, H; Wang, F; Wang, Y; Wu, C | 1 |
| Beer, AJ; Buck, AK; Eckel, F; Herrmann, K | 1 |
| Altomonte, J; Braren, R; Ebert, O; Esposito, I; Neff, F; Rummeny, E; Schwaiger, M; Settles, M; Steingoetter, A | 1 |
| Ahn, SH; Han, KH; Kang, WJ; Kim, BK; Kim, DY; Kim, JK; Lee, DY; Lee, JD; Lee, KH; Park, JY; Seong, J | 1 |
| Liu, S; Qiao, L; Tong, J; Wah Chan, K; Wang, B; Wang, Y | 1 |
| Bernstine, H; Braun, M; Carmi, R; Groshar, D; Lamash, Y; Sosna, J; Steinmetz, A; Stern, D; Yefremov, N | 1 |
| Cho, HJ; Han, KH; Kim, JW; Lee, IJ; Seong, J; Yoon, HI; Yun, M | 1 |
| Chan, AC; Chan, SC; Cheung, TT; Chok, KS; Fan, ST; Ho, CL; Lo, CM; Ng, KK; Poon, RT; Sharr, WW | 1 |
| He, TT; Tian, JH | 1 |
| Ahn, SH; Choi, HJ; Han, KH; Kim, DY; Lee, JD; Lee, JH; Park, JY; Seo, HJ | 1 |
| Gong, G; Hong, SJ; Hwang, DW; Lee, AL; Lee, JH; Lee, SR; Lee, YM; Park, KM; Sung, TY; Yoon, JH | 1 |
| Chatburn, L; Mercier, G; Peller, PJ; Sacks, A; Subramaniam, RM; Surasi, DS | 1 |
| Hatano, E; Higashi, T; Iida, T; Kitamura, K; Nakamoto, Y; Seo, S; Taura, K; Uemoto, S; Yamanaka, K; Yasuchika, K | 1 |
| Büchler, P; Friess, H; Gottschild, D; Kornberg, A; Krause, B; Küpper, B; Tannapfel, A; Witt, U | 1 |
| Mi, B; Wan, W; Xu, Q; You, X; Yu, C | 1 |
| Ahn, SG; Cho, HJ; Choi, SB; Jeon, TJ; Kim, KS; Kim, SH; Lee, JD; Yun, MJ | 1 |
| Li, BY; Li, HS; Wang, QS; Wang, QY; Wu, HB; Zhou, WL | 1 |
| Dong, MJ; Ouyang, XB; Pan, JH | 1 |
| Cheng, CY; Hou, CH; Lin, LF; Shen, DH | 1 |
| Corbin, DJ; Ko, YH; Lee, MJ; Pedersen, PL; Verhoeven, HA; Vogl, TJ | 1 |
| Freesmeyer, M; Lopatta, E; Opfermann, T; Schierz, JH; Settmacher, U; Steenbeck, J | 1 |
| Antoch, G; Bölke, E; Budach, W; Gerber, PA; Hautzel, H; Kröpil, P; Matuschek, C; Scherer, A; Zinnmann, F | 1 |
| Goethals, I; Lambert, B; Mees, G; Mertens, K; Van de Wiele, C | 1 |
| Ahn, BC; Gambhir, SS; Hofmann, LV; Katzenberg, R; Kim, YI; Paulmurugan, R; Ray, S; Ronald, JA; Singh, A | 1 |
| Dang, Y; Feng, R; Huo, L; Li, F; Zhuang, H | 1 |
| Kwee, SA; Lan, BY; Wong, LL | 1 |
| Hsieh, TC; Kao, CH; Sun, SS; Wu, YC; Yen, KY | 1 |
| Dall'Angelo, S; Li, XG; O'Hagan, D; Schweiger, LF; Zanda, M | 1 |
| Balogova, S; Fartoux, L; Huchet, V; Kerrou, K; Nataf, V; Rosmorduc, O; Talbot, JN | 1 |
| Bonomo, L; Castaldi, P; De Gaetano, AM; Filograna, L; Gatto, AM; Giordano, A; Rufini, V | 1 |
| Jadvar, H | 1 |
| Choi, YY; Jang, KS; Kim, JY; Kim, YH; Lee, JH; Lee, KG; Park, HK; Park, MH; Song, SY | 1 |
| Cha, SW; Cho, YD; Choi, DL; Jang, JY; Jeong, SW; Jin, SY; Kim, BS; Kim, HS; Kim, SG; Kim, YS; Lee, JE; Lee, SH | 1 |
| Bae, SH; Choi, BG; Choi, JY; Chun, HJ; Jang, JW; Lee, HG; Park, CH; Song, MJ; Yoo, IeR; Yoon, SK | 1 |
| Han, SS; Kim, C; Kim, SH; Kim, SK; Kim, YK; Lee, SD; Park, SJ | 1 |
| Ito, T; Kawabata, K; Noguchi, A; Okano, S; Shimizu, T; Tani, N; Yamaguchi, M; Yamane, T | 1 |
| Chen, W; Chen, Z; Liang, H; Rao, L; Shi, X; Wang, X; Yi, C; Zhang, X | 1 |
| Chan, SC; Chen, S; Cheung, TT; Chok, KS; Fan, ST; Fung, JY; Ho, CL; Lo, CM; Poon, RT; Sharr, W; Yan Chan, AC; Yau, T | 1 |
| Higashiyama, S; Kawabe, J; Koyama, K; Ochi, H; Okamura, T; Ozawa, N; Yamada, R | 1 |
| Ho, CL; Yeung, DW; Yu, SC | 1 |
| Delbeke, D; Pinson, CW | 1 |
| Alavi, A; Anderson, GS; Brinkmann, F; Soulen, MC; Zhuang, H | 1 |
| Chapman, WC; Delbeke, D; Morris, D; Pinson, CW; Rice, M; Shyr, Y; Washington, MK; Wudel, LJ | 1 |
| Delos, M; Krug, B; Lacrosse, M; Martinet, JP; Vander Borght, T | 1 |
| Böhm, B; Geoghegan, J; Gottschild, D; Hellfritzsch, H; Petrovich, A; Scheele, J; Voth, M | 1 |
| Fukuda, K; Koh, T; Kunishima, S; Taniguchi, H; Yamagishi, H | 1 |
| Chen, Y; He, XF; Li, YH; Liu, FY; Shang, JB; Wang, JY; Zeng, QL | 1 |
| Choi, Y; Choi, YH; Han, KH; Kim, JS; Kim, KS; Kim, SJ; Lee, JD; Lee, JM; Lee, WJ; Lim, SM; Park, JH; Park, YN; Yang, WI; Yoo, N; Yun, M | 1 |
| Gharib, AM; Li, KC; Thomasson, D | 1 |
| Futatsubashi, M; Kanno, T; Nakamura, F; Nakamura, S; Sakahara, H; Sugiyama, M; Torizuka, T | 1 |
| Kashiwagi, T | 1 |
| Cheon, GJ; Choi, CW; Han, CJ; Jeong, SH; Ki, SS; Kim, J; Kim, MJ; Kim, YC; Kong, YH; Lee, JO; Lee, SD; Lim, SM; Sohn, WS | 1 |
| Hung, GU; Lin, WY; Tsai, SC | 1 |
| Kuge, Y; Mochizuki, T; Nakada, K; Sato, M; Takahashi, T; Takei, T; Tamaki, N; Zhao, S | 1 |
| Helmberger, T; Jacobs, TF; Münzing, W; Pöpperl, G; Schmid, R; Tatsch, K | 1 |
| Blankenberg, FG; Kuge, Y; Sato, M; Strauss, HW; Tait, JF; Takei, T; Tamaki, N; Zhao, S | 1 |
| Kurtovic, J; Riordan, SM; Van Der Wall, H | 1 |
| Alison, ME; Balan, KK; Beadsmoore, CJ; Cheow, HK; Gibbs, P; Lomas, DJ; Sala, E; Save, V | 1 |
| Fan, WJ; Gu, YK; Huang, JH; Lin, YE; Tan, ZB; Wu, PH; Zeng, YX; Zhang, FJ; Zhang, L; Zhao, M | 1 |
| Ahn, YH; Cho, AE; Choi, CW; Choi, JS; Han, KH; Im, SS; Kim, HM; Kim, KS; Kim, TS; Ko, D; Lee, JD; Park, JH; Park, YN; Yang, WI; Yun, M | 1 |
| Hanajiri, K; Kondo, Y; Maruyama, T; Mitsui, H; Nakagawa, K; Omata, M; Shiina, S | 1 |
| Fartoux, L; Ganne, N; Grahek, D; Grange, JD; Gutman, F; Kerrou, K; Montravers, F; Poupon, R; Rosmorduc, O; Talbot, JN | 1 |
| Fujii, H; Hatano, E; Higashi, T; Ikai, I; Saga, T; Shimahara, Y; Teramukai, S; Torizuka, T | 1 |
| Chang, TH; Cheng, CY; Huang, WS; Lin, MH; Liu, CH; Shen, DH | 1 |
| Li, H; Wang, QS; Wang, XL; Zhang, XL | 1 |
| Cho, EH; Cho, JY; Cho, YB; Lee, HW; Lee, KU; Suh, KS; Yang, SH; Yi, NJ | 1 |
| An, M; Choi, JI; Hong, EK; Kim, CM; Kim, SH; Kim, SK; Lee, WJ; Park, JW; Park, SJ; Shin, JA | 1 |
| Hara, T; Hatano, E; Higashi, T; Ikai, I; Iwaisako, K; Seo, S; Tada, M; Tamaki, N; Uemoto, S | 1 |
| Chen, X; Dai, JZ; Dong, MJ; Guan, YH; Jiang, BD; Lin, XT; Zhao, J; Zuo, CT | 1 |
| Chen, S; Cheng, TK; Ho, CL; Yeung, DW | 1 |
| Altmann, A; Bonaterra, GA; Dimitrakopoulou-Strauss, A; Eisenhut, M; Haberkorn, U; Hoffend, J; Kinscherf, R; Schmidt, K; Strauss, LG | 1 |
| Guan, YS; Pan, WM; Sun, L; Wu, H | 1 |
| Kawashima, H; Kohanawa, M; Kuge, Y; Seki, K; Takahashi, T; Takei, T; Tamaki, N; Temma, T; Zhao, S; Zhao, Y | 1 |
| Cheng, MF; Huang, YH; Tzen, KY; Wu, YW; Yen, RF | 1 |
| Chen, GB; Guan, YS; Luo, ZM; Pan, WM; Sun, L; Wu, H | 1 |
| Endo, K; Hanaoka, H; Higuchi, T; Iida, Y; Ishikita, T; Miyakubo, M; Oriuchi, N; Paudyal, B; Paudyal, P; Takano, A; Tsushima, Y | 1 |
| Kim, J; Kim, S; Kostakoglu, L; Machac, J; Mocherla, B; Roayaie, S | 1 |
| Avila-Rodriguez, MA; Converse, AK; Hampel, JA; Jaskowiak, CJ; McDermott, JC; Nickles, RJ; Selwyn, RG; Thomadsen, BR; Warner, TF | 1 |
| Kanegae, K; Kohanawa, M; Kuge, Y; Seki, K; Takahashi, T; Tamaki, N; Yi, M; Zhao, S; Zhao, Y | 1 |
| Ahn, SH; Chon, CY; Han, KH; Kim, DY; Kim, JK; Lee, JD; Rha, SY; Yoon, KT; Yun, M | 1 |
| Endo, K; Higuchi, T; Ishikita, T; Miyakubo, M; Nakajima, T; Oriuchi, N; Paudyal, B; Paudyal, P; Tsushima, Y | 1 |
| Chen, GB; Guan, YS; Luo, ZM; Pan, WM; Sun, L; Wei, JH; Wu, H | 1 |
| Buchmann, I; Ganten, TM; Haberkorn, U | 1 |
| Inokuma, T; Konishi, J; Magata, Y; Sasayama, S; Tamaki, N; Tanaka, A; Torizuka, T; Yamamoto, K; Yamaoka, Y; Yonekura, Y | 1 |
| Hosokawa, C; Ikeda, H; Kamino, T; Kawabe, J; Ochi, H; Okamura, T; Onoyama, Y | 1 |
| Inokuma, T; Konishi, J; Magata, Y; Tamaki, N; Tanaka, A; Torizuka, T; Yamamoto, K; Yamaoka, Y; Yonekura, Y | 1 |
| Alpert, NM; Fischman, AJ; Goldberg, MA; Lee, MJ; Mueller, PR; Thrall, JH | 1 |
| Dimitrakopoulou-Strauss, A; Doll, J; Gutzler, F; Irngartinger, G; Oberdorfer, F; Strauss, LG; Stremmel, W; van Kaick, G | 1 |
| Blair, T; Blanke, C; Chapman, WC; Debelak, JP; Delbeke, D; Pinson, CW; Rose, AT; Rose, DM; Wright, JK | 1 |
| Baum, RP; Schröder, O; Trojan, J; Zeuzem, S | 1 |
| Fukuda, T; Jomura, H; Kawabe, J; Kawashima, D; Koyama, K; Kuroki, T; Ochi, H; Sasaki, N; Shiomi, S | 1 |
| Jomura, H; Kawabe, J; Kubo, S; Kuroki, T; Morikawa, H; Nishiguchi, S; Ochi, H; Sakaguchi, H; Sasaki, N; Seki, S; Shiomi, S | 1 |
| Aloj, L; Caracó, C; Eckelman, WC; Jagoda, E; Neumann, RD | 1 |
| Baum, RP; Herrmann, G; Jacobi, V; Raedle, J; Schroeder, O; Trojan, J; Zeuzem, S | 1 |
| Bender, H; Biersack, HJ; Caselmann, WH; Grünwald, F; Kersjes, W; Palmedo, H; Risse, JH; Strunk, H | 1 |
| Hansen, SB; Keiding, S; Munk, OL; Schiøtt, KM | 1 |
| Iwata, Y; Jomura, H; Kawabe, J; Nishiguchi, S; Ochi, H; Sasaki, N; Seki, S; Shiomi, S | 1 |
| Cachin, F; Lumbroso, J; Maublant, J; Raoul, JL; Syrota, A; Vuillez, JP | 1 |
| Draisma, A; Pauwels, EK; Stokkel, MP | 1 |
| Braga, FJ; Flamen, P; Homans, F; Maes, A; Mortelmans, L; Stroobants, S | 1 |
| Habu, D; Ishizu, H; Iwata, Y; Kubo, S; Nishiguchi, S; Ochi, H; Sasaki, N; Shiomi, S; Takeda, T; Tamori, A | 1 |
| Higashiyama, S; Inoue, Y; Kawabe, J; Koyama, K; Ochi, H; Ohachi, Y; Okamura, T; Sakamoto, H; Shakudo, M; Yamada, R | 1 |
| Nishiguchi, S; Shiomi, S | 1 |
| de Man, RA; Krenning, EP; Valkema, R; Verhoef, C; Yzermans, JN | 1 |
| Asano, T; Enomoto, K; Hayashi, H; Isono, K; Kikuchi, T; Okazumi, S; Ozaki, M; Ryu, M; Yamamoto, H | 1 |
| Eremin, O; Evans, NT; Gvozdanovic, D; Heys, SD; Mallard, JR; Roeda, D; Smith, FW | 1 |
| Asano, T; Enomoto, K; Fukunaga, T; Imazeki, K; Isono, K; Itoh, H; Kikuchi, T; Nagashima, T; Okazumi, S; Yamamoto, H | 1 |
| Fukuda, H | 1 |
| Ahonen, A; Nordman, E; Paul, R; Roeda, D | 1 |
30 review(s) available for fluorodeoxyglucose f18 and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Effect of metformin on
Topics: Animals; Breast Neoplasms; Carcinoma, Hepatocellular; Colonic Neoplasms; Diabetes Mellitus, Type 2; Energy Intake; Female; Fluorodeoxyglucose F18; Gastrointestinal Tract; Glucose; Humans; Hyperglycemia; Hypoglycemic Agents; Kidney; Liver Neoplasms; Metformin; Mice; Myocardium; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Thyroid Neoplasms; White Matter | 2022 |
The Diagnostic Value of Fibroblast Activation Protein Imaging in Hepatocellular Carcinoma and Cholangiocellular Carcinoma.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Cholangiocarcinoma; Fatty Liver; Fibroblasts; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Positron Emission Tomography Computed Tomography | 2023 |
Fluorodeoxyglucose PET for Monitoring Response to Embolotherapy (Transarterial Chemoembolization) in Primary and Metastatic Liver Tumors.
Topics: Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Female; Fluorodeoxyglucose F18; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Monitoring, Physiologic; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome; Tumor Microenvironment | 2019 |
The Unique Role of Fluorodeoxyglucose-PET in Radioembolization.
Topics: Brachytherapy; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Neoplasm Invasiveness; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Radiotherapy Dosage; Randomized Controlled Trials as Topic; Risk Assessment; Survival Analysis; Treatment Outcome; Yttrium Radioisotopes | 2019 |
Radiomics in Hepatocellular Carcinoma.
Topics: Carcinoma, Hepatocellular; Clinical Decision-Making; Early Detection of Cancer; Fluorodeoxyglucose F18; Genomics; Humans; Image Processing, Computer-Assisted; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Precision Medicine; Prognosis; Risk Assessment; Survival Rate; Tomography, X-Ray Computed | 2020 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
PET/MRI of the hepatobiliary system: Review of techniques and applications.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals | 2021 |
Topics: Adenoma, Liver Cell; Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies | 2021 |
Diagnostic test accuracies of F-18 FDG PET/CT for prediction of microvascular invasion of hepatocellular carcinoma: A meta-analysis.
Topics: Carcinoma, Hepatocellular; Diagnostic Tests, Routine; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2021 |
18F-FDG PET with or without CT in the diagnosis of extrahepatic metastases or local residual/recurrent hepatocellular carcinoma.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2018 |
Cancer Metabolism as a Mechanism of Treatment Resistance and Potential Therapeutic Target in Hepatocellular Carcinoma.
Topics: Acetates; Adult; Aged; Biomarkers, Tumor; Carbon; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2018 |
Current status of imaging biomarkers predicting the biological nature of hepatocellular carcinoma.
Topics: Aged; Biomarkers, Tumor; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Tomography, X-Ray Computed | 2019 |
Emerging role of
Topics: Biomarkers, Tumor; Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver; Liver Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Patient Selection; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Treatment Outcome; Tumor Burden | 2019 |
Clinical application of 18F-fluorodeoxyglucose positron emission tomography for assessment and evaluation after therapy for malignant hepatic tumor.
Topics: Carcinoma, Hepatocellular; Cholangiocarcinoma; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Multimodal Imaging; Neoplasm, Residual; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Positron emission tomography diagnostic imaging in multidrug-resistant hepatocellular carcinoma: focus on 2-deoxy-2-(18F)Fluoro-D-Glucose.
Topics: Carcinoma, Hepatocellular; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Multidrug Resistance-Associated Proteins; Positron-Emission Tomography; Radiography; Radiopharmaceuticals | 2014 |
[18F]fludeoxyglucose positron emission tomography and computed tomography as a prognostic tool before liver transplantation, resection, and loco-ablative therapies for hepatocellular carcinoma.
Topics: Algorithms; Carcinoma, Hepatocellular; Cost-Benefit Analysis; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Liver Transplantation; Multimodal Imaging; Neoplasm Invasiveness; Neoplasm Metastasis; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Recurrence; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
Prediction of hepatocellular carcinoma biological behavior in patient selection for liver transplantation.
Topics: alpha-Fetoproteins; Biomarkers; Biomarkers, Tumor; Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Liver Transplantation; Patient Selection; Positron-Emission Tomography; Prognosis; Protein Precursors; Prothrombin; RNA, Messenger | 2016 |
Prognostic significance of parameters from pretreatment (18)F-FDG PET in hepatocellular carcinoma: a meta-analysis.
Topics: Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals | 2016 |
Clinical applications and advances of positron emission tomography with fluorine-18-fluorodeoxyglucose (18F-FDG) in the diagnosis of liver neoplasms.
Topics: Carcinoma, Hepatocellular; Cholangiocarcinoma; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2008 |
Modified RECIST (mRECIST) assessment for hepatocellular carcinoma.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Clinical Trials as Topic; Diagnostic Imaging; Drug Delivery Systems; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Neoplasm Staging; Outcome Assessment, Health Care; Positron-Emission Tomography; Practice Guidelines as Topic; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
PET-CT scan is a valuable modality in the diagnosis of fibrolamellar hepatocellular carcinoma: a case report and a summary of recent literature.
Topics: Adult; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed; Young Adult | 2011 |
Application of positron emission tomography molecular probes in hepatocellular carcinoma biological imaging.
Topics: Animals; Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Positron-Emission Tomography | 2011 |
Value of PET/CT in the management of primary hepatobiliary tumors, part 2.
Topics: Acetates; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carbon Radioisotopes; Carcinoma, Hepatocellular; Cholangiocarcinoma; Fluorodeoxyglucose F18; Gallbladder Neoplasms; Humans; Liver Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
Positron emission tomography in hepatobiliary and pancreatic malignancies: a review.
Topics: Carcinoma, Hepatocellular; Cholangiocarcinoma; Digestive System Neoplasms; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2012 |
Clinical applications of (18)F-FDG PET in the management of hepatobiliary and pancreatic tumors.
Topics: Adenocarcinoma; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biliary Tract Neoplasms; Carcinoma, Hepatocellular; Cholangiocarcinoma; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Liver Neoplasms; Multimodal Imaging; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
Hepatocellular carcinoma and gastroenteropancreatic neuroendocrine tumors: potential role of other positron emission tomography radiotracers.
Topics: Animals; Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Intestinal Neoplasms; Liver Neoplasms; Neuroendocrine Tumors; Pancreatic Neoplasms; Positron-Emission Tomography; Radioactive Tracers; Stomach Neoplasms | 2012 |
[[18F]-FDG-PET in the diagnostics of gastrointestinal tumors].
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Cholangiocarcinoma; Colonic Neoplasms; Esophageal Neoplasms; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Liver Neoplasms; Meta-Analysis as Topic; Neoplasm Recurrence, Local; Neoplasm Staging; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
[Nuclear medicine in oncology: new diagnostic and therapeutic methods].
Topics: Carcinoma, Hepatocellular; Contraindications; Contrast Media; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Iodized Oil; Liver Neoplasms; Lymphatic Metastasis; Medical Oncology; Neoplasms; Nuclear Medicine; Radioimmunotherapy; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
Positron emission tomography with 2-[18F]-fluoro-2-deoxy-D-glucose in oncology. Part IIIb: Therapy response monitoring in colorectal and lung tumours, head and neck cancer, hepatocellular carcinoma and sarcoma.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Bone Neoplasms; Carcinoma, Hepatocellular; Colorectal Neoplasms; Evaluation Studies as Topic; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Liver Neoplasms; Lung Neoplasms; Male; Neoplasm Metastasis; Neoplasms; Outcome Assessment, Health Care; Sarcoma; Soft Tissue Neoplasms; Tomography, Emission-Computed | 2001 |
[Nuclear medicine(FDG-PET)].
Topics: Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Prognosis; Radiopharmaceuticals; Survival Rate; Tomography, Emission-Computed | 2001 |
14 trial(s) available for fluorodeoxyglucose f18 and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Functional Imaging of Liver Cancer (FLIC): Study protocol of a phase 2 trial of 18F-DCFPyL PET/CT imaging for patients with hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Clinical Trials, Phase II as Topic; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Positron Emission Tomography Computed Tomography; Prospective Studies; Prostatic Neoplasms; Urea | 2022 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Proposal of a New Preoperative Prognostic Model for Solitary Hepatocellular Carcinoma Incorporating
Topics: Adult; Aged; Aged, 80 and over; Bilirubin; Biomarkers, Tumor; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Preoperative Care; Prognosis; Prospective Studies; Radiopharmaceuticals; Retrospective Studies; Serum Albumin; Survival Rate | 2018 |
Prediction of tumor recurrence by 18F-FDG PET in liver transplantation for hepatocellular carcinoma.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2009 |
Detection of hepatocellular carcinoma with PET/CT: a prospective comparison of 18F-fluorocholine and 18F-FDG in patients with cirrhosis or chronic liver disease.
Topics: Biological Transport; Carcinoma, Hepatocellular; Cell Differentiation; Choline; Chronic Disease; Female; Fluorodeoxyglucose F18; Humans; Liver Cirrhosis; Liver Neoplasms; Magnetic Resonance Imaging; Male; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Reproducibility of Results; Tomography, X-Ray Computed | 2010 |
A pilot comparison of 18F-fluorodeoxyglucose and 18F-fluorocholine PET/CT to predict early recurrence of unifocal hepatocellular carcinoma after surgical resection.
Topics: Aged; Carcinoma, Hepatocellular; Choline; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Pilot Projects; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
The usefulness of 18F-FDG PET images obtained 2 hours after intravenous injection in liver tumor.
Topics: Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Colorectal Neoplasms; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Injections, Intravenous; Liver Neoplasms; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Time Factors | 2002 |
11C-acetate PET imaging in hepatocellular carcinoma and other liver masses.
Topics: Acetates; Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carbon Radioisotopes; Carcinoma, Hepatocellular; Cholangiocarcinoma; Colonic Neoplasms; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2003 |
Relationships between oxygen and glucose metabolism in human liver tumours: positron emission tomography using (15)O and (18)F-deoxyglucose.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Glucose; Humans; Liver; Liver Neoplasms; Middle Aged; Neovascularization, Pathologic; Oxygen; Oxygen Radioisotopes; Positron-Emission Tomography; Radiopharmaceuticals; Statistics as Topic | 2004 |
Analysis of gene expression profiles of hepatocellular carcinomas with regard to 18F-fluorodeoxyglucose uptake pattern on positron emission tomography.
Topics: Adult; Aged; Biomarkers, Tumor; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Proteins; Oligonucleotide Array Sequence Analysis; Organ Specificity; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Severity of Illness Index; Statistics as Topic; Tissue Distribution | 2004 |
Value of delayed 18F-FDG-PET imaging in the detection of hepatocellular carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Injections, Intravenous; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Time Factors | 2005 |
Value of fluorine-18-FDG-PET to monitor hepatocellular carcinoma after interventional therapy.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Iodized Oil; Liver Neoplasms; Male; Middle Aged; Necrosis; Tomography, Emission-Computed | 1994 |
Intraarterial HCC therapy with I-131-Lipiodol.
Topics: Aged; Aged, 80 and over; Brachytherapy; Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Germany; Hepatic Artery; Humans; Injections, Intra-Arterial; Iodine Radioisotopes; Iodized Oil; Liver Neoplasms; Middle Aged; Radiopharmaceuticals; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2000 |
Usefulness of positron emission tomography with fluorine-18-fluorodeoxyglucose for predicting outcome in patients with hepatocellular carcinoma.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Cell Division; Female; Fluorodeoxyglucose F18; Forecasting; Humans; Liver Neoplasms; Male; Middle Aged; Survival Rate; Tomography, Emission-Computed | 2001 |
291 other study(ies) available for fluorodeoxyglucose f18 and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Undetectable Brain Metastasis of Hepatocellular Carcinoma by PET-CT After Liver Transplantation: a Case Report.
Topics: alpha-Fetoproteins; Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Liver Transplantation; Living Donors; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2023 |
Extrahepatic metastases of hepatocellular carcinoma on
Topics: Carcinoma, Hepatocellular; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2021 |
Dynamic chaotic gravitational search algorithm-based kinetic parameter estimation of hepatocellular carcinoma on
Topics: Algorithms; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Liver Neoplasms; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2022 |
The value of 18F-FDG PET/MRI in prediction of microvascular invasion in hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Retrospective Studies | 2022 |
PET-Based Radiogenomics Supports mTOR Pathway Targeting for Hepatocellular Carcinoma.
Topics: Animals; Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Mice; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; TOR Serine-Threonine Kinases | 2022 |
Pretreatment Positron Emission Tomography with 18F-Fluorodeoxyglucose May Be a Useful New Predictor of Early Progressive Disease following Atezolizumab plus Bevacizumab in Patients with Unresectable Hepatocellular Carcinoma.
Topics: Antibodies, Monoclonal, Humanized; Bevacizumab; Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2022 |
18F-FDG PET/CT Imaging in Sarcomatoid Hepatocellular Carcinoma.
Topics: Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2022 |
A Recanalized Umbilical Vein Hypermetabolic Thrombosis Mimicked an Hepatocellular Carcinoma Recurrence: A New Pitfall?
Topics: Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Positron Emission Tomography Computed Tomography; Thrombosis; Umbilical Veins; Venous Thrombosis; Yttrium Radioisotopes | 2022 |
Total Lesion Glycolysis on 18F-FDG PET/CT Is a Better Prognostic Factor Than Tumor Dose on 90Y PET/CT in Patients With Hepatocellular Carcinoma Treated With 90Y Transarterial Radioembolization.
Topics: Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Liver Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Tumor Burden; Yttrium Radioisotopes | 2022 |
Preoperative clinical-radiomics nomogram for microvascular invasion prediction in hepatocellular carcinoma using [Formula: see text]F-FDG PET/CT.
Topics: Carcinoma, Hepatocellular; China; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Nomograms; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2022 |
The role of volumetric and textural analysis of pretreatment 18F-fluorodeoxyglucose PET/computerized tomography images in predicting complete response to transarterial radioembolization in hepatocellular cancer.
Topics: Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Glycolysis; Humans; Liver Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Retrospective Studies; Tumor Burden | 2022 |
A case of hepatocellular carcinoma with long-term survival by multidisciplinary treatment for cranial and skeletal muscle metastases.
Topics: Carcinoma, Hepatocellular; Drugs, Investigational; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Muscle, Skeletal; Skull; Sorafenib; Tegafur | 2022 |
Budd-Chiari syndrome secondary to tumor thrombus of hepatocellular carcinoma detected by
Topics: Budd-Chiari Syndrome; Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Positron Emission Tomography Computed Tomography; Thrombosis | 2022 |
Towards refining the utility of dual (18F-FDG / 18F-Choline) PET/CT for the management of hepatocellular carcinoma: a tertiary center study.
Topics: alpha-Fetoproteins; Carcinoma, Hepatocellular; Choline; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Retrospective Studies | 2023 |
Impact of 68 Ga-FAPI-04 PET/CT on Staging and Therapeutic Management in Patients With Digestive System Tumors.
Topics: Adenocarcinoma; Carcinoma, Hepatocellular; Carcinoma, Pancreatic Ductal; Colonic Neoplasms; Digestive System Neoplasms; Fluorodeoxyglucose F18; Gallium Radioisotopes; Gastrointestinal Neoplasms; Humans; Liver Neoplasms; Neuroendocrine Tumors; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography | 2023 |
Different 18F-FDG imaging: A rare case of liver multiple carcinomas.
Topics: Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Glucose; Humans; Liver Neoplasms; Male; Middle Aged; Radiopharmaceuticals | 2023 |
Kinetic parameter estimation of hepatocellular carcinoma on
Topics: Bayes Theorem; Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2023 |
Hot Gloved Finger Sign in Endobronchial Metastasis From Hepatocellular Carcinoma on FDG PET/CT.
Topics: Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2023 |
[
Topics: Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Liver Neoplasms; Positron Emission Tomography Computed Tomography; Quinolines | 2023 |
Mixed neuroendocrine carcinoma and hepatocellular carcinoma in the liver.
Topics: Aged; Carcinoma, Hepatocellular; Carcinoma, Neuroendocrine; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2023 |
Solitary Accessory Spleen-Like Metastasis Coexisted With Splenic Infarction Reveled on 18F-FDG PET/CT in a Hepatocellular Carcinoma Patient.
Topics: Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Splenic Infarction | 2023 |
Complete Metabolic Response by 18 F-FDG PET/CT to Atezolizumab Plus Bevacizumab in Patients With Advanced Hepatocellular Carcinoma.
Topics: Aged; Bevacizumab; Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Positron Emission Tomography Computed Tomography | 2023 |
Is 18 F-FDG/ 18 F-Choline Dual-Tracer PET Behavior a Surrogate of Tumor Differentiation in Hepatocellular Carcinoma : A Tertiary Center Dedicated Study.
Topics: Carcinoma, Hepatocellular; Choline; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2023 |
Role of textural analysis parameters derived from FDG PET/CT in differentiating hepatocellular carcinoma and hepatic metastases.
Topics: Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Positron Emission Tomography Computed Tomography; Retrospective Studies; Tomography, X-Ray Computed; Tumor Microenvironment | 2023 |
Role of 68 Ga-FAPI PET/CT in Assessing Hepatobiliary Malignancies : A Prospective Pilot Study.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Cholangiocarcinoma; Fibroblasts; Fluorodeoxyglucose F18; Gallium Radioisotopes; Gastrointestinal Neoplasms; Humans; Liver Neoplasms; Pilot Projects; Positron Emission Tomography Computed Tomography; Prospective Studies | 2023 |
FAPI PET Positivity in Fibrolamellar Hepatocellular Carcinoma.
Topics: Adult; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Liver Neoplasms; Positron Emission Tomography Computed Tomography | 2023 |
The added value of
Topics: Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Keratin-19; Liver Neoplasms; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2023 |
Relationship between SUVmax on 18F-FDG PET and PD-L1 expression in hepatocellular carcinoma.
Topics: B7-H1 Antigen; Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2023 |
18 F-FDG PET/MRI of Primary Hepatic Malignancies: Differential Diagnosis and Histologic Grading
Topics: Carcinoma, Hepatocellular; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Positron-Emission Tomography; Retrospective Studies | 2024 |
The role of
Topics: Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Immune Checkpoint Inhibitors; Liver Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Programmed Cell Death 1 Receptor | 2023 |
PET imaging with FAPI-ligands for non-cirrhotic hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Liver Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Quinolines | 2023 |
PET imaging of tumor vascular normalization in hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Positron-Emission Tomography | 2023 |
Primary Hepatocellular Carcinoma Revealed on 68 Ga-DOTATATE in a Patient With Nasopharyngeal Carcinoma.
Topics: Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Prospective Studies | 2023 |
Differentiation of Discordant Lesions on Dual-Tracer PET/CT (
Topics: Carcinoma, Hepatocellular; Cell Differentiation; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Liver Neoplasms; Male; Neoplasms, Second Primary; Oligopeptides; Positron Emission Tomography Computed Tomography; Prostate; Prostatic Neoplasms | 2023 |
A Head-to-Head Comparison of 68Ga-LNC1007 and 2-18F-FDG/68Ga-FAPI-02 PET/CT in Patients With Various Cancers.
Topics: Carcinoma, Hepatocellular; Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Liver Neoplasms; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography | 2023 |
Integrin α6 targeted positron emission tomography imaging of hepatocellular carcinoma in mouse models.
Topics: Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Fluorodeoxyglucose F18; Humans; Integrin alpha6; Liver; Liver Neoplasms, Experimental; Mice; Mice, Nude; Oligopeptides; Positron-Emission Tomography; Tissue Distribution | 2019 |
Commentary on "FDG-PET predicted unfavorable tumor histology in living donor liver transplant recipients; a retrospective cohort study".
Topics: Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Liver Transplantation; Living Donors; Positron-Emission Tomography; Retrospective Studies; Transplant Recipients | 2019 |
Benign hepatic incidentalomas.
Topics: Carcinoma, Hepatocellular; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Incidental Findings; Liver; Liver Diseases; Magnetic Resonance Imaging; Practice Guidelines as Topic; Tomography, X-Ray Computed; Ultrasonography | 2019 |
Improving patient selection in Living-Donor Liver transplantation: Prognostication with pre-transplant 18-fluoro-deoxyglucose Positron Emission Tomography.
Topics: Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Liver Transplantation; Living Donors; Patient Selection; Positron-Emission Tomography; Retrospective Studies; Transplant Recipients | 2019 |
FDG PET Findings of Hyperprogression During Immunotherapy in a Patient With Hepatocellular Carcinoma.
Topics: Adult; Carcinoma, Hepatocellular; Disease Progression; Fluorodeoxyglucose F18; Humans; Immunotherapy; Liver Neoplasms; Male; Positron-Emission Tomography; Radiopharmaceuticals | 2020 |
Hypoxia-induced modulation of glucose transporter expression impacts
Topics: Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Glucose Transporter Type 3; Humans; Hypoxia; Liver Neoplasms; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2020 |
Comparison of different kinetic models for dynamic
Topics: Algorithms; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Hepatic Artery; Humans; Image Processing, Computer-Assisted; Kinetics; Liver Neoplasms; Male; Middle Aged; Models, Biological; Positron Emission Tomography Computed Tomography | 2020 |
Preoperative PET-CT is useful for predicting recurrent extrahepatic metastasis of hepatocellular carcinoma after resection.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Preoperative Care; Proportional Hazards Models; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity | 2020 |
Primary Hepatocellular Carcinoma With Intense 68Ga-PSMA Uptake But Slight 18F-FDG Uptake on PET/CT Imaging.
Topics: Aged; Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Gallium Isotopes; Gallium Radioisotopes; Humans; Liver Neoplasms; Male; Membrane Glycoproteins; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2020 |
The critical role of glucose deprivation in epithelial-mesenchymal transition in hepatocellular carcinoma under hypoxia.
Topics: Adult; Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Proliferation; Epithelial-Mesenchymal Transition; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Glucose; Hep G2 Cells; Humans; Hypoxia; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Middle Aged; Positron Emission Tomography Computed Tomography; Tumor Microenvironment | 2020 |
Combined DCE-MRI- and FDG-PET enable histopathological grading prediction in a rat model of hepatocellular carcinoma.
Topics: Animals; Carcinoma, Hepatocellular; Contrast Media; Disease Models, Animal; Fluorodeoxyglucose F18; Image Enhancement; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Neoplasm Grading; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Wistar; Sensitivity and Specificity; Tumor Burden | 2020 |
Correlation Between von Hippel-Lindau Gene Expression and Tumor SUVmax and Survival Prognosis in Hepatocellular Carcinoma.
Topics: Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Glucose; Glucose Transporter Type 1; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Prognosis; Survival Analysis; Von Hippel-Lindau Tumor Suppressor Protein | 2020 |
The Role of 18F-FDG PET/MRI in the Assessment of Primary Intrahepatic Neoplasms.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2021 |
Addition of [
Topics: Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Liver Transplantation; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2020 |
Alpha-fetoprotein and
Topics: alpha-Fetoproteins; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplastic Cells, Circulating; Portal Vein; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Period; Radiopharmaceuticals; Risk Factors; Survival Rate; Tumor Burden | 2020 |
Hepatobiliary MR contrast agent uptake as a predictive biomarker of aggressive features on pathology and reduced recurrence-free survival in resectable hepatocellular carcinoma: comparison with dual-tracer 18F-FDG and 18F-FCH PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Choline; Contrast Media; Disease-Free Survival; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Neoplasm Staging; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Recurrence; Retrospective Studies | 2020 |
Prognostic value of
Topics: Adult; Aged; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiofrequency Ablation; Radiopharmaceuticals | 2020 |
Potential and Clinical Significance of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Evaluating Liver Cancer Response to Lenvatinib Treatment.
Topics: Administration, Oral; Aged; Aged, 80 and over; alpha-Fetoproteins; Antineoplastic Agents; Carcinoma, Hepatocellular; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver Neoplasms; Male; Middle Aged; Phenylurea Compounds; Positron Emission Tomography Computed Tomography; Prognosis; Quinolines; Retrospective Studies; Treatment Outcome | 2021 |
Prognostic value of LI-RADS category on gadoxetic acid-enhanced MRI and 18F-FDG PET-CT in patients with primary liver carcinomas.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Contrast Media; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies | 2021 |
18-FDG PET/CT provides solid evidence of microvascular invasion and is correlated with prognosis in patients with hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis | 2021 |
Investigating the value of pre-treatment
Topics: Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Liver Transplantation; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2021 |
Differences in diagnostic impact of dual-tracer PET/computed tomography according to the extrahepatic metastatic site in patients with hepatocellular carcinoma.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2021 |
Extrahepatic metastases from hepatocellular carcinoma: multimodality image evaluation.
Topics: Aged; Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Middle Aged; Positron Emission Tomography Computed Tomography | 2021 |
FDG PET/CT to Detect Incidental Findings in Patients With Hepatocellular Carcinoma-Additional Benefit for Patients Considered for Liver Transplantation?
Topics: Adult; Aged; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Liver Neoplasms; Liver Transplantation; Magnetic Resonance Imaging; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies; Ultrasonography | 2021 |
An FDG PET/CT metabolic parameter-based nomogram for predicting the early recurrence of hepatocellular carcinoma after liver transplantation.
Topics: Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Liver Transplantation; Neoplasm Recurrence, Local; Nomograms; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2021 |
Radiation-Induced Metabolic Shifts in the Hepatic Parenchyma: Findings from
Topics: Animals; Biomarkers; Carcinoma, Hepatocellular; Energy Metabolism; Fluorodeoxyglucose F18; Gluconeogenesis; Glycolysis; Humans; Liver Neoplasms; Magnetic Resonance Spectroscopy; Metabolic Networks and Pathways; Metabolomics; Mice; Positron-Emission Tomography | 2021 |
Dynamic
Topics: Adult; Aged; Aorta, Thoracic; Bile Duct Neoplasms; Carcinoma, Hepatocellular; Cholangiocarcinoma; Female; Fluorodeoxyglucose F18; Hepatic Artery; Humans; Liver Neoplasms; Male; Middle Aged; Portal Vein; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2021 |
Feasibility of perfusion and early-uptake
Topics: Carcinoma, Hepatocellular; Feasibility Studies; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Perfusion; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies | 2021 |
Pretreatment Positron Emission Tomography with 18F-Fluorodeoxyglucose May Be a Useful New Predictor of Overall Prognosis Following Lenvatinib Treatment.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Phenylurea Compounds; Positron Emission Tomography Computed Tomography; Prognosis; Quinolines; Radiopharmaceuticals; Survival Rate; Treatment Outcome | 2021 |
Radiomics analysis of [
Topics: Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis | 2021 |
Identifying Patients Who May Benefit from Liver Resection Compared to Living Donor Liver Transplantation for Hepatocellular Carcinoma Using
Topics: Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Liver Transplantation; Living Donors; Neoplasm Recurrence, Local; Positron-Emission Tomography; Retrospective Studies; Treatment Outcome | 2021 |
The value of [
Topics: Acetates; Aged; Arteries; Bevacizumab; Carbon; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Survival Analysis; Treatment Outcome | 2017 |
Role of [
Topics: Adult; Carcinoma, Hepatocellular; Clinical Decision-Making; Disease Progression; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Patient Selection; Positron-Emission Tomography; Predictive Value of Tests; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome | 2017 |
18 F-FDG PET/MR imaging in patients with suspected liver lesions: Value of liver-specific contrast agent Gadobenate dimeglumine.
Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Hepatocellular; Cholangiocarcinoma; Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Melanoma; Middle Aged; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2017 |
Volumetric parameters on FDG PET can predict early intrahepatic recurrence-free survival in patients with hepatocellular carcinoma after curative surgical resection.
Topics: Carcinoma, Hepatocellular; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies | 2017 |
Is FCH PET able to identify foci of infection superiorly to FDG PET?
Topics: Anti-Bacterial Agents; Brain Abscess; Carcinoma, Hepatocellular; Diagnosis, Differential; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Streptococcal Infections; Streptococcus milleri Group | 2017 |
The uptake exploration of 68Ga-labeled NGR in well-differentiated hepatocellular carcinoma xenografts: Indication for the new clinical translational of a tracer based on NGR.
Topics: Animals; Carcinoma, Hepatocellular; CD13 Antigens; Cell Line, Tumor; Fluorodeoxyglucose F18; Gallium Radioisotopes; HT29 Cells; Humans; Liver Neoplasms; Mice; Neoplasm Transplantation; Oligopeptides; Positron Emission Tomography Computed Tomography; Tissue Distribution | 2017 |
Differentiation of Malignant Thrombus From Bland Thrombus of the Portal Vein in Patient With Hepatocellular Carcinoma on 18F-FDG PET CT.
Topics: Carcinoma, Hepatocellular; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Portal Vein; Positron Emission Tomography Computed Tomography; Venous Thrombosis | 2017 |
Combining
Topics: Aged; Carcinoma, Hepatocellular; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Patient Selection; Positron-Emission Tomography; Preoperative Care; Retrospective Studies; Treatment Outcome | 2017 |
Small Bowel Metastasis From Hepatocellular Carcinoma Detected by 18F-FDG PET/CT But Not by 11C-Acetate PET/CT.
Topics: Acetates; Adult; Carbon Radioisotopes; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Intestinal Neoplasms; Intestine, Small; Liver Neoplasms; Positron Emission Tomography Computed Tomography | 2017 |
Topics: Carcinoma, Hepatocellular; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Niacinamide; Phenylurea Compounds; Positron Emission Tomography Computed Tomography; Retrospective Studies; Sorafenib; Treatment Outcome | 2018 |
Preoperative prediction of microvascular invasion of hepatocellular carcinoma using
Topics: Aged; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2018 |
Positron emission tomography/computed tomography with 18F-fluorocholine improve tumor staging and treatment allocation in patients with hepatocellular carcinoma.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Choline; Female; Fluorodeoxyglucose F18; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Patient Selection; Positron Emission Tomography Computed Tomography; Radioactive Tracers; Radiopharmaceuticals; Reproducibility of Results | 2018 |
Castleman disease in the hilum liver mimicking the lymph node metastasis of hepatocellular carcinoma on 18F-FDG PET/CT: A case report.
Topics: Carcinoma, Hepatocellular; Castleman Disease; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2018 |
Prognostic value of pretreatment PET/CT lean body mass-corrected parameters in patients with hepatocellular carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Body Weight; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Survival Analysis; Tumor Burden | 2018 |
Pedunculated Hepatocellular Carcinoma Mimicking Right Adrenal Tumor on FDG PET/CT.
Topics: Adrenal Gland Neoplasms; Carcinoma, Hepatocellular; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2018 |
11C-acetate and 18F-fluorodeoxyglucose positron emission tomography/computed tomography dual imaging for the prediction of response and prognosis after transarterial chemoembolization.
Topics: Acetates; Adult; Aged; Aged, 80 and over; Carbon; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Female; Fluorodeoxyglucose F18; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Regression Analysis; Retrospective Studies; Treatment Outcome | 2018 |
Thyroid Metastasis From Hepatocellular Carcinoma Visualized by 18F-FDG PET/CT Imaging.
Topics: Adult; Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Thyroid Neoplasms | 2018 |
ASO Author Reflections: Proposal of a New Preoperative Prognostic Model for Solitary Hepatocellular Carcinoma.
Topics: Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Positron-Emission Tomography; Prognosis | 2018 |
Change in standardized uptake values in delayed 18F-FDG positron emission tomography images in hepatocellular carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reference Standards; Spleen; Young Adult | 2018 |
18F-FDG PET/CT of Internal Mammary Lymph Node Hepatocellular Carcinoma Metastases.
Topics: Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mammary Glands, Human; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2018 |
18F-FDG PET/CT predicts microvascular invasion and early recurrence after liver resection for hepatocellular carcinoma: A prospective observational study.
Topics: Aged; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver Neoplasms; Male; Microvessels; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Postoperative Period; Prognosis; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Time Factors; Vascular Neoplasms | 2019 |
FDG PET/CT Imaging of Hepatocellular Carcinoma With Bile Duct Tumor Thrombus.
Topics: Bile Duct Neoplasms; Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Thrombosis | 2019 |
Telbivudine-Induced Myopathy Incidentally Detected by FDG PET/CT Imaging in a Patient With History of Hepatocellular Carcinoma.
Topics: Aged; Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Incidental Findings; Liver Neoplasms; Male; Muscular Diseases; Positron Emission Tomography Computed Tomography; Telbivudine | 2019 |
Heterogeneous Uptake of 18F-FDG and 68Ga-PSMA-11 in Hepatocellular Carcinoma.
Topics: Aged, 80 and over; Biological Transport; Biopsy; Carcinoma, Hepatocellular; Edetic Acid; Fluorodeoxyglucose F18; Gallium Isotopes; Gallium Radioisotopes; Humans; Liver Neoplasms; Male; Oligopeptides; Positron Emission Tomography Computed Tomography | 2019 |
Evaluation of Iodine-125 Interstitial Brachytherapy Using Micro-Positron Emission Tomography/Computed Tomography with 18F-Fluorodeoxyglucose in Hepatocellular Carcinoma HepG2 Xenografts.
Topics: Animals; Brachytherapy; Carcinoma, Hepatocellular; Cell Line, Tumor; Fluorodeoxyglucose F18; Hep G2 Cells; Heterografts; Humans; Iodine Radioisotopes; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, Emission-Computed; Xenograft Model Antitumor Assays | 2019 |
Comparison of PERCIST and RECIST criteria for evaluation of therapy response after yttrium-90 microsphere therapy in patients with hepatocellular carcinoma and those with metastatic colorectal carcinoma.
Topics: Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Positron Emission Tomography Computed Tomography; Response Evaluation Criteria in Solid Tumors; Yttrium Radioisotopes | 2019 |
Value of
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Portal Vein; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Venous Thrombosis; Young Adult | 2019 |
Prognostic value of
Topics: Adult; Aged; Bile Duct Neoplasms; Carcinoma, Hepatocellular; Cholangiocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals | 2019 |
Diffusion-weighted MRI and
Topics: Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Diffusion Magnetic Resonance Imaging; Dose-Response Relationship, Radiation; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Macrophages; Male; Mice; Mice, Inbred BALB C; Positron-Emission Tomography; Radiopharmaceuticals; RAW 264.7 Cells; Tumor Microenvironment | 2019 |
Rapidly Lethal Ruptured Hepatocellular Carcinoma With Disseminated Peritoneal Carcinomatosis on FDG PET/CT.
Topics: Aged; Carcinoma, Hepatocellular; Fatty Liver; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography | 2019 |
FDG-PET predicted unfavorable tumor histology in living donor liver transplant recipients; a retrospective cohort study.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Liver Transplantation; Living Donors; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2019 |
18F-fluorodeoxyglucose PET/CT predicts tumour progression after transarterial chemoembolization in hepatocellular carcinoma.
Topics: Adolescent; Adult; Aged; Arteries; Carcinoma, Hepatocellular; Disease Progression; Embolization, Therapeutic; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Multivariate Analysis; Prognosis; Retrospective Studies; Time Factors; Treatment Outcome; Young Adult | 2013 |
Castleman disease of the porta hepatis mimicking exophytic hepatocellular carcinoma on CT, MRI, and FDG PET/CT.
Topics: Carcinoma, Hepatocellular; Castleman Disease; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2014 |
Early dynamic 18F-FDG PET to detect hyperperfusion in hepatocellular carcinoma liver lesions.
Topics: Adult; Aged; Blood Circulation; Carcinoma, Hepatocellular; Endpoint Determination; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Neovascularization, Pathologic; Positron-Emission Tomography; Time Factors; Whole Body Imaging | 2013 |
Multimodal assessment of in vivo metabolism with hyperpolarized [1-13C]MR spectroscopy and 18F-FDG PET imaging in hepatocellular carcinoma tumor-bearing rats.
Topics: Animals; Carbon Isotopes; Carcinoma, Hepatocellular; Cell Line, Tumor; Fluorodeoxyglucose F18; Liver Neoplasms; Magnetic Resonance Spectroscopy; Male; Positron-Emission Tomography; Protons; Radiopharmaceuticals; Rats | 2013 |
Value of ¹⁸F-FDG-PET/CT in the detection of recurrent hepatocellular carcinoma after hepatectomy or radiofrequency ablation: a comparative study with contrast-enhanced ultrasound.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Catheter Ablation; Female; Fluorodeoxyglucose F18; Hepatectomy; Humans; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography | 2013 |
Role of ¹⁸F-FDG PET CT as an independent prognostic indicator in patients with hepatocellular carcinoma.
Topics: Adult; Aged; Biological Transport; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Patient Selection; Positron-Emission Tomography; Prognosis; Retrospective Studies; Tomography, X-Ray Computed | 2013 |
Underestimated role of 18F-FDG PET for HCC evaluation and promise of 18F-FDG PET/MR imaging in this setting.
Topics: Carbon Radioisotopes; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Liver Transplantation; Male; Neoplasm Staging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2013 |
Reply: Underestimated role of 18F-FDG PET for HCC evaluation and promise of 18F-FDG PET/MR imaging in this setting.
Topics: Carbon Radioisotopes; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Liver Transplantation; Male; Neoplasm Staging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2013 |
A survival benefit of major hepatectomy for hepatocellular carcinoma identified by preoperative [18F] fluorodeoxyglucose positron emission tomography in patients with well-preserved hepatic function.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Cohort Studies; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Hepatectomy; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Multivariate Analysis; Neoplasms, Multiple Primary; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Treatment Outcome | 2013 |
¹⁸F-FDG PET metabolic parameters and MRI perfusion and diffusion parameters in hepatocellular carcinoma: a preliminary study.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Perfusion Imaging; Positron-Emission Tomography; Retrospective Studies | 2013 |
18F-FDG PET and combined 18F-FDG-contrast CT parameters as predictors of tumor control for hepatocellular carcinoma after stereotactic ablative radiotherapy.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Radiosurgery; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
FDG PET/CT and enhanced CT imaging of tumor heterogeneity in hepatocellular carcinoma: imaging-pathologic correlation.
Topics: Adult; Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Image Enhancement; Liver Neoplasms; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Molecular mechanisms of [18F]fluorodeoxyglucose accumulation in liver cancer.
Topics: Aged; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Glucose; Glucose Transporter Type 1; Glucose Transporter Type 2; Glucose-6-Phosphatase; Glucose-6-Phosphate; Hepatectomy; Hexokinase; Humans; Liver; Liver Neoplasms; Male; Positron-Emission Tomography; Proliferating Cell Nuclear Antigen; Radiopharmaceuticals; RNA, Messenger | 2014 |
Non-local means denoising of dynamic PET images.
Topics: Analysis of Variance; Animals; Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Image Processing, Computer-Assisted; Liver Neoplasms; Mice; Phantoms, Imaging; Positron-Emission Tomography; Signal-To-Noise Ratio | 2013 |
Clinical utility and limitations of FDG PET in detecting recurrent hepatocellular carcinoma in postoperative patients.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Postoperative Period; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2014 |
New scoring system for prediction of microvascular invasion in patients with hepatocellular carcinoma.
Topics: Aged; Area Under Curve; Biomarkers; Biomarkers, Tumor; Carcinoma, Hepatocellular; Decision Support Techniques; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Microvessels; Middle Aged; Neoplasm Invasiveness; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Protein Precursors; Prothrombin; Radiopharmaceuticals; Risk Factors; ROC Curve; Tumor Burden | 2014 |
FDG-PET predicts outcomes of treated bone metastasis following palliative radiotherapy in patients with hepatocellular carcinoma.
Topics: Adult; Aged; Bone Neoplasms; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Palliative Care; Positron-Emission Tomography; Radiopharmaceuticals; Republic of Korea; Treatment Outcome | 2014 |
Assessment of [(18)F]-fluoroacetate PET/CT as a tumor-imaging modality: preclinical study in healthy volunteers and clinical evaluation in patients with liver tumor.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Cholangiocarcinoma; Colonic Neoplasms; Female; Fluoroacetates; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tissue Distribution; Tomography, X-Ray Computed; Whole Body Imaging | 2014 |
Positioning of 18F-fluorodeoxyglucose-positron emission tomography imaging in the management algorithm of hepatocellular carcinoma.
Topics: Aged; Algorithms; Carcinoma, Hepatocellular; Cohort Studies; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2014 |
[Comparison analysis of multi-modalities images in 158 patients with hepatic tumor].
Topics: Adult; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography | 2014 |
Positive lymph node metastasis has a marked impact on the long-term survival of patients with hepatocellular carcinoma with extrahepatic metastasis.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymph Nodes; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Survival Analysis; Tomography, Emission-Computed | 2014 |
Survival in patients with hepatocellular carcinoma treated with 90Y-microsphere radioembolization. Prediction by 18F-FDG PET.
Topics: Adult; Aged; Aged, 80 and over; Brachytherapy; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Survival Rate; Yttrium Radioisotopes | 2014 |
The prognostic value of 18F-FDG PET/CT for hepatocellular carcinoma treated with transarterial chemoembolization (TACE).
Topics: Adult; Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Clinical Value of 18F-FDG PET/CT in Detecting Adrenal Metastasis in Patients with Hepatocellular Carcinoma.
Topics: Adrenal Gland Neoplasms; Adult; Carcinoma, Hepatocellular; False Positive Reactions; Female; Fluorodeoxyglucose F18; Hepacivirus; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2015 |
Tumor thrombus: ancillary findings on FDG PET/CT in an oncologic population.
Topics: Adolescent; Adult; Aged; Carcinoma, Hepatocellular; Carcinoma, Renal Cell; Child; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasms; Portal Vein; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Thrombosis; Tomography, X-Ray Computed; Veins; Vena Cava, Inferior; Venous Thromboembolism; Young Adult | 2014 |
[Value of (18)F-FDG PET in preoperative TACE of hepatocellular carcinoma].
Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Female; Fluorodeoxyglucose F18; Glucose; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Survival Rate | 2014 |
Correlation between biological marker expression and fluorine-18 fluorodeoxyglucose uptake in hepatocellular carcinoma.
Topics: Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Liver Neoplasms; Male; Middle Aged; Phosphorylation; Radionuclide Imaging; STAT3 Transcription Factor | 2014 |
Does 18F-FDG positron emission tomography-computed tomography have a role in initial staging of hepatocellular carcinoma?
Topics: Adult; Aged; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography | 2014 |
[Synchronous hepatocellular carcinoma and B-cell non-Hodgkin's lymphoma in chronic hepatitis C patient].
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Drug Therapy, Combination; Embolization, Therapeutic; Fluorodeoxyglucose F18; Gadolinium DTPA; Genotype; Hepatitis B virus; Hepatitis C, Chronic; Humans; Liver Neoplasms; Lymph Nodes; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed | 2014 |
Prediction of microvascular invasion of hepatocellular carcinoma using gadoxetic acid-enhanced MR and (18)F-FDG PET/CT.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Image Enhancement; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Microvessels; Middle Aged; Multimodal Imaging; Neoplasm Invasiveness; Neovascularization, Pathologic; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Monitoring Tumor Response After Histone Deacetylase Inhibitor Treatment Using 3'-Deoxy-3'-[18F]-fluorothymidine PET.
Topics: Animals; Carcinoma, Hepatocellular; Cell Cycle; Cell Proliferation; Cell Survival; Disease Models, Animal; Fluorodeoxyglucose F18; Hep G2 Cells; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Immunohistochemistry; Liver Neoplasms; Male; Mice; Neoplasm Transplantation; Positron-Emission Tomography; Vorinostat | 2015 |
Evaluation of diethylnitrosamine- or hepatitis B virus X gene-induced hepatocellular carcinoma with 18F-FDG PET/CT: a preclinical study.
Topics: Animals; Carcinoma, Hepatocellular; Diethylnitrosamine; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Hexokinase; Liver Neoplasms, Experimental; Longitudinal Studies; Magnetic Resonance Imaging; Male; Mice, Inbred C57BL; Mice, Transgenic; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Trans-Activators; Viral Regulatory and Accessory Proteins | 2015 |
[Feasibility study of ¹⁸F-fluorodeoxyglucose positron emission tomography/computed tomography in proposing selection criteria for patients with hepatocellular carcinoma in liver transplantation].
Topics: alpha-Fetoproteins; Carcinoma, Hepatocellular; Disease-Free Survival; Feasibility Studies; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Liver Transplantation; Multimodal Imaging; Patient Selection; Positron-Emission Tomography; Risk Factors; ROC Curve; Tomography, X-Ray Computed | 2014 |
Value of 18F-FDG PET/CT in detecting viable tumour and predicting prognosis of hepatocellular carcinoma after TACE.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Fluorodeoxyglucose F18; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; ROC Curve; Tomography, X-Ray Computed | 2015 |
¹⁸F-FDG PET/CT in hepatocellular carcinoma: detection of bone metastasis and prediction of prognosis.
Topics: Adult; Aged; Bone and Bones; Bone Neoplasms; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Retrospective Studies; Sensitivity and Specificity; Survival Analysis; Tomography, X-Ray Computed | 2015 |
Combined early dynamic (18)F-FDG PET/CT and conventional whole-body (18)F-FDG PET/CT provide one-stop imaging for detecting hepatocellular carcinoma.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Whole Body Imaging | 2015 |
Solitary splenic metastasis from hepatocellular carcinoma detected on (18)F-FDG PET/CT.
Topics: Aged; Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Multimodal Imaging; Radionuclide Imaging; Radiopharmaceuticals; Splenic Neoplasms; Tomography, X-Ray Computed | 2015 |
Predictability of preoperative 18F-FDG PET for histopathological differentiation and early recurrence of primary malignant intrahepatic tumors.
Topics: Adult; Aged; Bile Duct Neoplasms; Carcinoma, Hepatocellular; Cholangiocarcinoma; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Multivariate Analysis; Positron-Emission Tomography; Preoperative Period; Prognosis; Recurrence; Retrospective Studies | 2015 |
Extended Ischemia Times Promote Risk of HCC Recurrence in Liver Transplant Patients.
Topics: Adult; Aged; alpha-Fetoproteins; Carcinoma, Hepatocellular; Cold Ischemia; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Reperfusion Injury; Retrospective Studies; Risk Factors; Survival Rate; Time Factors; Warm Ischemia | 2015 |
The predictive value of metabolic tumor volume on FDG PET/CT for transarterial chemoembolization and transarterial chemotherapy infusion in hepatocellular carcinoma patients without extrahepatic metastasis.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Female; Fluorodeoxyglucose F18; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden | 2015 |
[A case report of surgical treatment for hepatocellular carcinoma with a Hugely swollen lymph node that showed high FDG uptake].
Topics: Aged; Carcinoma, Hepatocellular; Embolization, Therapeutic; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence | 2014 |
Prognostic value of (18)F-FDG PET/CT in liver transplantation for hepatocarcinoma.
Topics: Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
The role of 18F-FDG accumulation and arterial enhancement as biomarkers in the assessment of typing, grading and staging of hepatocellular carcinoma using 18F-FDG-PET/CT with integrated dual-phase CT angiography.
Topics: Adult; Aged; Aged, 80 and over; Angiography; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed | 2015 |
Pretransplant serum levels of C-reactive protein predict prognoses in patients undergoing liver transplantation for hepatocellular carcinoma.
Topics: Adult; Aged; C-Reactive Protein; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Multivariate Analysis; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Tomography, X-Ray Computed | 2015 |
Clinical Impact of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Living Donor Liver Transplantation for Advanced Hepatocellular Carcinoma.
Topics: Aged; Carcinoma, Hepatocellular; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Liver Transplantation; Living Donors; Male; Microcirculation; Middle Aged; Multimodal Imaging; Multivariate Analysis; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
Evaluation of 11C-acetate and 18F-FDG PET/CT in mouse multidrug resistance gene-2 deficient mouse model of hepatocellular carcinoma.
Topics: Acetates; Animals; ATP Binding Cassette Transporter, Subfamily B; ATP-Binding Cassette Sub-Family B Member 4; Carbon; Carcinoma, Hepatocellular; Disease Models, Animal; Fluorodeoxyglucose F18; Liver Neoplasms; Mice; Mice, Knockout; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Use of (18)F-FDG PET to predict tumor progression and survival in patients with intermediate hepatocellular carcinoma treated by transarterial chemoembolization.
Topics: Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
18F-FDG PET CT as a prognostic factor in hepatocellular carcinoma.
Topics: Adult; Aged; Aged, 80 and over; alpha-Fetoproteins; Aspartate Aminotransferases; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Female; Fluorodeoxyglucose F18; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Tumor Burden | 2015 |
Important factors determining prognosis based on SUVmax in PET imaging.
Topics: Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
A Case of Oral Metastasis From Hepatocellular Carcinoma Displayed on 18F-FDG PET/CT Imaging.
Topics: Aged; Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Mouth Neoplasms; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2016 |
Predictors of Microvascular Invasion in Hepatocellular Carcinoma.
Topics: Biomarkers; Biomarkers, Tumor; Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Microvessels; Neoplasm Invasiveness; Positron-Emission Tomography; Protein Precursors; Prothrombin; Radiopharmaceuticals | 2015 |
Role of 18F-FDG PET/CT Imaging in Intrahepatic Cholangiocarcinoma.
Topics: Adult; Aged; Aged, 80 and over; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biomarkers, Tumor; Carcinoma, Hepatocellular; Cholangiocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Klatskin Tumor; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2016 |
Evaluation of 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in rat models with hepatocellular carcinoma with liver cirrhosis.
Topics: Animals; Carcinoma, Hepatocellular; Diethylnitrosamine; Feasibility Studies; Fluorodeoxyglucose F18; Liver Cirrhosis; Liver Neoplasms; Male; Metabolic Clearance Rate; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution; Tomography, X-Ray Computed | 2015 |
Prognostic Value of 18-Fluorodeoxyglucose-Positron Emission Tomography After Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma Undergoing Orthotopic Liver Transplantation.
Topics: Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Multimodal Imaging; Necrosis; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome; Vascular Surgical Procedures | 2015 |
18F-FDG PET in Liver Transplantation Setting of Hepatocellular Carcinoma: Predicting Histology?
Topics: Adult; Aged; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2016 |
Diagnostic value of combining ¹¹C-choline and ¹⁸F-FDG PET/CT in hepatocellular carcinoma.
Topics: Aged; Aged, 80 and over; Carbon Radioisotopes; Carcinoma, Hepatocellular; Choline; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals | 2016 |
Alpha-fetoprotein and (18)F-FDG positron emission tomography predict tumor recurrence better than Milan criteria in living donor liver transplantation.
Topics: Adult; Aged; alpha-Fetoproteins; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Liver Transplantation; Living Donors; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography | 2016 |
Prognostic Significance of ¹⁸F-FDG Uptake in Hepatocellular Carcinoma Treated with Transarterial Chemoembolization or Concurrent Chemoradiotherapy: A Multicenter Retrospective Cohort Study.
Topics: Adult; Aged; Aged, 80 and over; Aging; Carcinoma, Hepatocellular; Chemoradiotherapy; Cohort Studies; Disease-Free Survival; Embolization, Therapeutic; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Liver; Liver Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Analysis | 2016 |
Increased 18F-FDG Uptake on PET/CT is Associated With Poor Arterial and Portal Perfusion on Multiphase CT.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Perfusion Imaging; Portal System; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2016 |
Radiation Dosimetry of Whole-Body Dual-Tracer 18F-FDG and 11C-Acetate PET/CT for Hepatocellular Carcinoma.
Topics: Acetates; Aged; Aged, 80 and over; Carbon Radioisotopes; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radioactive Tracers; Radiometry; Retrospective Studies; Risk; Whole Body Imaging | 2016 |
Functional imaging of hepatocellular carcinoma using diffusion-weighted MRI and (18)F-FDG PET/CT in patients on waiting-list for liver transplantation.
Topics: Ablation Techniques; Aged; alpha-Fetoproteins; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Neoplasm Grading; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome; Waiting Lists | 2016 |
Use of 18F-FDG PET Scan and Ultrasound-guided Biopsy in the Diagnosis of Hepatic Carcinomas.
Topics: Adult; Aged; Bile Duct Neoplasms; Carcinoma, Hepatocellular; Cholangiocarcinoma; Cohort Studies; Female; Fluorodeoxyglucose F18; Hepatectomy; Humans; Image-Guided Biopsy; Liver; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Tumor Burden; Ultrasonography | 2015 |
18F-FDG PET/CT of Primary Mediastinal Hepatoid Adenocarcinoma.
Topics: Adenocarcinoma; Carcinoma, Hepatocellular; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Mediastinal Neoplasms; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2016 |
Prognostic value of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with Barcelona Clinic Liver Cancer stages 0 and A hepatocellular carcinomas: a multicenter retrospective cohort study.
Topics: Aged; Biological Transport; Carcinoma, Hepatocellular; Cohort Studies; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2016 |
New Approach for Treatment of Primary Liver Tumors: The Role of Quercetin.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; bcl-2-Associated X Protein; Carcinoma, Hepatocellular; Cell Cycle; Cell Line, Tumor; Cell Survival; DNA Damage; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Hep G2 Cells; Humans; Liver Neoplasms; Niacinamide; Phenylurea Compounds; Proto-Oncogene Proteins c-bcl-2; Quercetin; Sorafenib; Tumor Suppressor Protein p53 | 2016 |
A non-smooth tumor margin on preoperative imaging predicts microvascular invasion of hepatocellular carcinoma.
Topics: Aged; Carcinoma, Hepatocellular; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Microvessels; Middle Aged; Multivariate Analysis; Neoplasm Invasiveness; Positron-Emission Tomography; Radiopharmaceuticals; Vascular Neoplasms | 2016 |
Prediction of Posttransplantation Recurrence of Hepatocellular Carcinoma Using Metabolic and Volumetric Indices of 18F-FDG PET/CT.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; ROC Curve; Treatment Outcome; Young Adult | 2016 |
Combination of FDG-PET and UCSF Criteria for Predicting HCC Recurrence After Living Donor Liver Transplantation.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Chi-Square Distribution; Decision Support Techniques; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Liver Transplantation; Living Donors; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome | 2016 |
Diagnosis of Hepatocellular Carcinoma Using C11 Choline PET/CT: Comparison with F18 FDG, ContrastEnhanced MRI and MDCT.
Topics: Adult; Carcinoma, Hepatocellular; Choline; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Ultrasonography | 2016 |
Unusual Presentation of Bone Metastasis from Hepatocellular Carcinoma Mimicking as Breast Lump.
Topics: Bone Neoplasms; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Thoracic Neoplasms; Thoracic Wall; Tomography, X-Ray Computed | 2016 |
Prognostic Value of FDG Uptake of Portal Vein Tumor Thrombosis in Patients With Locally Advanced Hepatocellular Carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Chemoradiotherapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Portal Vein; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Venous Thrombosis | 2017 |
Prognostic Value of Metabolic Tumor Volume and Total Lesion Glycolysis on Preoperative 18F-FDG PET/CT in Patients With Very Early and Early Hepatocellular Carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Liver Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals | 2017 |
Risk stratification for locally advanced hepatocellular carcinoma using pretreatment alpha-foetoprotein and
Topics: Adolescent; Adult; Aged; Aged, 80 and over; alpha-Fetoproteins; Biomarkers; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Multivariate Analysis; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Republic of Korea; Retrospective Studies; Risk Assessment; Survival Analysis; Young Adult | 2017 |
Significance of preoperative fluorodeoxyglucose-positron emission tomography in prediction of tumor recurrence after liver transplantation for hepatocellular carcinoma patients: a Japanese multicenter study.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Cause of Death; Cohort Studies; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Hospital Mortality; Humans; Japan; Kaplan-Meier Estimate; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Care; Prognosis; Proportional Hazards Models; Retrospective Studies; Risk Assessment; ROC Curve; Survival Analysis; Tissue Donors; Treatment Outcome | 2017 |
Prognostic Value of Metabolic Parameters of 18F-FDG PET/CT and Apparent Diffusion Coefficient of MRI in Hepatocellular Carcinoma.
Topics: Aged; Carcinoma, Hepatocellular; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies | 2017 |
Prognostic value of pre-treatment F-18-FDG PET-CT in patients with hepatocellular carcinoma undergoing radioembolization.
Topics: Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Chi-Square Distribution; Disease Progression; Disease-Free Survival; Embolization, Therapeutic; Female; Florida; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Microspheres; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome; Yttrium Radioisotopes | 2016 |
Predictive Value of 18F-FDG PET/CT for Vascular Invasion in Patients With Hepatocellular Carcinoma Before Liver Transplantation.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Neoplasm Invasiveness; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Preoperative Period; Radiopharmaceuticals | 2017 |
90Y Liver Radioembolization Imaging Using Amplitude-Based Gated PET/CT.
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Yttrium Radioisotopes | 2017 |
Prognostic effect of transarterial chemoembolization-induced complete pathological response in patients undergoing liver resection and transplantation for hepatocellular carcinoma.
Topics: Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Liver; Liver Neoplasms; Liver Transplantation; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Postoperative Period; Prognosis; Recurrence; Republic of Korea; Retrospective Studies; Time Factors; Treatment Outcome | 2017 |
Low Utility of Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography for Detecting Hepatocellular Carcinoma in Patients Before Liver Transplantation.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Databases, Factual; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Liver Transplantation; Living Donors; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Risk Factors; Treatment Outcome; Young Adult | 2017 |
18F-Fluorodeoxyglucose positron emission tomography for monitoring response to sorafenib treatment in patients with hepatocellular carcinoma.
Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Niacinamide; Phenylurea Compounds; Positron-Emission Tomography; Protein Kinase Inhibitors; Pyridines; Radiopharmaceuticals; Receptors, Vascular Endothelial Growth Factor; Sorafenib | 2008 |
Detection of hepatocellular carcinoma using 11C-choline PET: comparison with 18F-FDG PET.
Topics: Aged; Carbon Radioisotopes; Carcinoma, Hepatocellular; Choline; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2008 |
F-18 FDG PET imaging of fibrolamellar hepatocellular carcinoma.
Topics: Adolescent; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography | 2008 |
Clinical implication of glucose transport and metabolism evaluated by 18F-FDG PET in hepatocellular carcinoma.
Topics: Aged; Blotting, Western; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Glucose; Glucose Transport Proteins, Facilitative; Glucose Transporter Type 2; Hexokinase; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Proportional Hazards Models; Radiopharmaceuticals; Risk Assessment; Treatment Outcome | 2008 |
2-[18F]-2-deoxy-D-glucose (FDG) uptake in human tumor cells is related to the expression of GLUT-1 and hexokinase II.
Topics: Animals; Blotting, Western; Carcinoma, Hepatocellular; Disease Models, Animal; Feasibility Studies; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Hexokinase; Humans; Image Processing, Computer-Assisted; Liver Neoplasms, Experimental; Mice; Mice, SCID; Positron-Emission Tomography; Radiopharmaceuticals; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2008 |
A prospective evaluation of 18F-FDG and 11C-acetate PET/CT for detection of primary and metastatic hepatocellular carcinoma.
Topics: Acetates; Adult; Carbon; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Incidence; Korea; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Subtraction Technique; Survival Analysis; Survival Rate; Tomography, X-Ray Computed | 2008 |
Duodenal metastasis from hepatocelluar carcinoma demonstrated on FDG PET/CT imaging.
Topics: Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Duodenal Neoplasms; Duodenoscopy; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Liver Transplantation; Male; Positron-Emission Tomography; Tomography, X-Ray Computed | 2008 |
PET imaging of hepatocellular carcinoma with 2-deoxy-2[18F]fluoro-D-glucose, 6-deoxy-6[18F] fluoro-D-glucose, [1-11C]-acetate and [N-methyl-11C]-choline.
Topics: Acetates; Animals; Carbon; Carcinoma, Hepatocellular; Choline; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Marmota; Oligonucleotide Array Sequence Analysis; Positron-Emission Tomography; Radiopharmaceuticals; Reverse Transcriptase Polymerase Chain Reaction; Staining and Labeling; Tomography, X-Ray Computed | 2009 |
Radiofrequency ablation of liver tumors using a novel bipolar device.
Topics: Aged; Carcinoma, Hepatocellular; Catheter Ablation; Equipment Design; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome | 2008 |
18F-FDG-uptake of hepatocellular carcinoma on PET predicts microvascular tumor invasion in liver transplant patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Neoplasm Invasiveness; Positron-Emission Tomography; Recurrence; Survival Rate | 2009 |
Gingival tumor as the first sign of advanced hepatocellular carcinoma on FDG PET/CT.
Topics: Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Gingival Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed | 2009 |
P-glycoprotein expression affects 18F-fluorodeoxyglucose accumulation in hepatocellular carcinoma in vivo and in vitro.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Calcium Channel Blockers; Carcinoma, Hepatocellular; Cell Differentiation; Disease Progression; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Glucose Transporter Type 2; Glucose-6-Phosphatase; Hexokinase; Humans; Liver Neoplasms; Models, Biological; Radionuclide Imaging; Tumor Cells, Cultured; Verapamil | 2009 |
FDG PET for monitoring response to local and locoregional therapy in HCC and liver metastases.
Topics: Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Prognosis; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Radiotherapy Dosage; Treatment Outcome | 2009 |
The importance of acetyl coenzyme A synthetase for 11C-acetate uptake and cell survival in hepatocellular carcinoma.
Topics: Acetate-CoA Ligase; Acetates; Adult; Aged; Carbon; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Fatty Acid Synthases; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Metabolic Clearance Rate; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals | 2009 |
Evaluation of the role of hexokinase type II in cellular proliferation and apoptosis using human hepatocellular carcinoma cell lines.
Topics: Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Fluorodeoxyglucose F18; Hexokinase; Humans; Liver Neoplasms; Radionuclide Imaging; Radiopharmaceuticals | 2009 |
18F-FDG-PET and histopathology in 131I-lipiodol treatment for primary liver cancer.
Topics: Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Iodized Oil; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2009 |
FDG PET as a prognostic predictor in the early post-therapeutic evaluation for unresectable hepatocellular carcinoma.
Topics: Adult; Aged; Analysis of Variance; Biological Transport; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Retrospective Studies; Survival Rate; Time Factors | 2010 |
Comparison of the tumorigenic potential of liver and kidney tumors induced by N-nitrosodimethylamine.
Topics: Analysis of Variance; Animals; Autoradiography; Biomarkers, Tumor; Blotting, Western; Carcinogenicity Tests; Carcinoma, Hepatocellular; Cell Cycle; Cell Line, Tumor; Dimethylnitrosamine; Flow Cytometry; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Glucose Transporter Type 3; Immunohistochemistry; Kidney; Kidney Neoplasms; Liver; Liver Neoplasms; Mesenchymoma; Microscopy, Fluorescence; Radionuclide Imaging; Rats; Transforming Growth Factor beta1 | 2010 |
[Preliminary study on the validity of whole body diffusion-weighted imaging for the detection of malignant lesions].
Topics: Adolescent; Adult; Aged; Carcinoma, Hepatocellular; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Neoplasms; Positron-Emission Tomography; Stomach Neoplasms; Whole Body Imaging; Young Adult | 2010 |
Usefulness 18F-FDG positron emission tomography/computed tomography for detecting recurrence of hepatocellular carcinoma in posttransplant patients.
Topics: Adult; Bone Neoplasms; Brain Neoplasms; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Liver Transplantation; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Reoperation; Republic of Korea; Time Factors; Tomography, Spiral Computed; Treatment Outcome | 2010 |
[Hepatocellular carcinoma and cholangiocarcinoma].
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biopsy; Carcinoma, Hepatocellular; Cholangiocarcinoma; Cholangiopancreatography, Endoscopic Retrograde; Combined Modality Therapy; Contrast Media; Fluorodeoxyglucose F18; Hepatectomy; Humans; Liver Neoplasms; Liver Transplantation; Magnetic Resonance Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2010 |
Prognostic implication of (18)F FDG-PET in patients with extrahepatic metastatic hepatocellular carcinoma undergoing systemic treatment, a retrospective cohort study.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Hepatocellular; Cohort Studies; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Molecular Targeted Therapy; Neoplasm Recurrence, Local; Palliative Care; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate | 2011 |
PET/CT characteristics of isolated bone metastases in hepatocellular carcinoma.
Topics: Acetates; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiography; Radiopharmaceuticals; Survival Rate | 2011 |
Evaluation of metabolic characteristics and viability of lipiodolized hepatocellular carcinomas using 18F-FDG PET/CT.
Topics: Adult; Aged; alpha-Fetoproteins; Carcinoma, Hepatocellular; Contrast Media; Embolization, Therapeutic; Ethiodized Oil; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Tomography, Emission-Computed | 2010 |
Imaging lipid synthesis in hepatocellular carcinoma with [methyl-11c]choline: correlation with in vivo metabolic studies.
Topics: Animals; Betaine; Carbon Radioisotopes; Carcinoma, Hepatocellular; Choline; Choline Kinase; Choline-Phosphate Cytidylyltransferase; Fluorodeoxyglucose F18; Lipids; Liver Neoplasms; Marmota; Phosphatidylcholines; Positron-Emission Tomography; Radiopharmaceuticals | 2011 |
Pancreatic and hepatobiliary cancers.
Topics: Biliary Tract Neoplasms; Carcinoma, Hepatocellular; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Middle Aged; Octreotide; Organometallic Compounds; Pancreas; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2011 |
Validation of preclinical multiparametric imaging for prediction of necrosis in hepatocellular carcinoma after embolization.
Topics: Animals; Carcinoma, Hepatocellular; Contrast Media; Embolization, Therapeutic; Extravasation of Diagnostic and Therapeutic Materials; Fluorodeoxyglucose F18; Liver Neoplasms; Magnetic Resonance Imaging; Male; Multivariate Analysis; Necrosis; Positron-Emission Tomography; Predictive Value of Tests; Rats; Rats, Inbred BUF; Tumor Burden | 2011 |
18F-fluorodeoxyglucose uptake on positron emission tomography as a prognostic predictor in locally advanced hepatocellular carcinoma.
Topics: Adult; Aged; Analysis of Variance; Carcinoma, Hepatocellular; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Drug Administration Schedule; Female; Fluorodeoxyglucose F18; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Radiotherapy Dosage; Research Design; Treatment Outcome | 2011 |
FDG PET/CT early dynamic blood flow and late standardized uptake value determination in hepatocellular carcinoma.
Topics: Aged; Aged, 80 and over; Blood Flow Velocity; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Neovascularization, Pathologic; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; ROC Curve; Statistics, Nonparametric; Tomography, X-Ray Computed | 2011 |
Usefulness of positron emission tomography with fluorine-18-fluorodeoxyglucose in predicting treatment response in unresectable hepatocellular carcinoma patients treated with external beam radiotherapy.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Fluorouracil; Glucose; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Remission Induction; Retrospective Studies; Treatment Outcome | 2012 |
Can positron emission tomography with the dual tracers [11 C]acetate and [18 F]fludeoxyglucose predict microvascular invasion in hepatocellular carcinoma?
Topics: Acetates; Adult; Aged; Aged, 80 and over; Carbon; Carcinoma, Hepatocellular; Chi-Square Distribution; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Hepatectomy; Hong Kong; Humans; Liver Neoplasms; Liver Transplantation; Male; Microvessels; Middle Aged; Neoplasm Invasiveness; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Care; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Survival Analysis; Survival Rate; Time Factors; Treatment Outcome | 2011 |
Prognostic value of 18F-FDG PET for hepatocellular carcinoma patients treated with sorafenib.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Benzenesulfonates; Carcinoma, Hepatocellular; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Niacinamide; Phenylurea Compounds; Positron-Emission Tomography; Predictive Value of Tests; Proportional Hazards Models; Protein Kinase Inhibitors; Pyridines; Radiopharmaceuticals; Republic of Korea; Retrospective Studies; Risk Assessment; Risk Factors; Sorafenib; Survival Rate; Time Factors; Treatment Outcome; Young Adult | 2011 |
Hepatocellular carcinoma eats medullary thyroid carcinoma, a case of tumor-in-tumor metastasis.
Topics: Carcinoma, Hepatocellular; Carcinoma, Medullary; Fluorodeoxyglucose F18; Histocytochemistry; Humans; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Thyroid Neoplasms; Ultrasonography | 2011 |
Preoperative FDG-PET predicts recurrence patterns in hepatocellular carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Preoperative Care; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate | 2012 |
Patients with non-[18 F]fludeoxyglucose-avid advanced hepatocellular carcinoma on clinical staging may achieve long-term recurrence-free survival after liver transplantation.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Liver; Liver Neoplasms; Liver Transplantation; Longitudinal Studies; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiography; Retrospective Studies; Survival Rate; Treatment Outcome | 2012 |
Sarcomatoid hepatocellular carcinoma diagnosed by FDG PET/CT.
Topics: Aged; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Multimodal Imaging; Positron-Emission Tomography; Sarcoma; Tomography, X-Ray Computed; Ultrasonography | 2011 |
The role of preoperative [18F]fluorodeoxyglucose positron emission tomography in predicting early recurrence after curative resection of hepatocellular carcinomas.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Disease-Free Survival; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Time Factors | 2011 |
F-18 FDG in conjunction with 11C-choline PET/CT in the diagnosis of hepatocellular carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carbon Radioisotopes; Carcinoma, Hepatocellular; Choline; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Tomography, X-Ray Computed; Whole Body Imaging | 2011 |
A hepatoid adenocarcinoma of the stomach with liver metastasis mimicking hepatocellular carcinoma detected by F-18 FDG PET/CT imaging.
Topics: Adenocarcinoma; Aged; Carcinoma, Hepatocellular; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Multimodal Imaging; Positron-Emission Tomography; Stomach Neoplasms; Tomography, X-Ray Computed | 2011 |
Unusual Tc-99m methylene diphosphonate uptake by clinically suspected adrenal metastases from hepatocellular carcinoma.
Topics: Adrenal Gland Neoplasms; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Middle Aged; Positron-Emission Tomography; Technetium Tc 99m Medronate; Tomography, X-Ray Computed | 2011 |
A translational study "case report" on the small molecule "energy blocker" 3-bromopyruvate (3BP) as a potent anticancer agent: from bench side to bedside.
Topics: Adolescent; Ammonia; Antineoplastic Agents, Alkylating; Carcinoma, Hepatocellular; Energy Metabolism; Fatal Outcome; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Molecular Structure; Positron-Emission Tomography; Pyruvates; Translational Research, Biomedical; Urea; Uric Acid | 2012 |
Early dynamic PET imaging shows hypervascularization as exact as contrast-enhanced MR.
Topics: Aged; Carcinoma, Hepatocellular; Contrast Media; Early Diagnosis; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Neovascularization, Pathologic; Positron-Emission Tomography; Radiopharmaceuticals | 2012 |
Pitfalls in radiation oncology. "Myocardial metastasis" in PET-CT after palliative radiation treatment of the left 5th rib.
Topics: Bone Neoplasms; Carcinoma, Hepatocellular; Diagnostic Errors; Fluorodeoxyglucose F18; Heart Neoplasms; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Multimodal Imaging; Myocardium; Neoplasm Staging; Palliative Care; Positron-Emission Tomography; Radiation Injuries; Radiotherapy Planning, Computer-Assisted; Ribs; Tomography, X-Ray Computed | 2012 |
In vitro 2-deoxy-2-[18F]fluoro-D-glucose uptake: practical considerations.
Topics: Brain Neoplasms; Carcinoma, Hepatocellular; Cell Count; Cell Proliferation; Colorectal Neoplasms; Culture Media; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Hexokinase; Humans; Immunoenzyme Techniques; Liver Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Time Factors; Tumor Cells, Cultured | 2012 |
Intratumoral versus intravenous gene therapy using a transcriptionally targeted viral vector in an orthotopic hepatocellular carcinoma rat model.
Topics: Adenoviridae; Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Feasibility Studies; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Genes, Reporter; Genetic Therapy; Genetic Vectors; Inhibitor of Apoptosis Proteins; Injections, Intralesional; Injections, Intravenous; Liver Neoplasms; Luciferases, Firefly; Luminescent Measurements; Positron-Emission Tomography; Promoter Regions, Genetic; Radiopharmaceuticals; Rats; Rats, Inbred BUF; Time Factors; TNF-Related Apoptosis-Inducing Ligand; Transcription, Genetic; Transduction, Genetic | 2012 |
Hepatocelluar carcinoma in an accessory lobe of the liver revealed by 11C-acetate PET with a negative finding on FDG imaging.
Topics: Acetates; Aged; Carbon Radioisotopes; Carcinoma, Hepatocellular; False Negative Reactions; Fluorodeoxyglucose F18; Humans; Liver; Liver Neoplasms; Male; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2012 |
Bilateral breast uptake demonstrated on FDG PET/CT scans in 3 male patients with hepatocellular carcinomas.
Topics: Breast; Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Mammography; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2012 |
[18F]-5-Fluoro-5-deoxyribose, an efficient peptide bioconjugation ligand for positron emission tomography (PET) imaging.
Topics: Carcinoma, Hepatocellular; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Hydrogen-Ion Concentration; Ligands; Liver Neoplasms; Oximes; Peptides; Positron-Emission Tomography; Receptor, PAR-2 | 2012 |
Inflammatory pseudotumor of the kidney mimicking malignancy on 18F-FDG PET/CT in a patient with diabetes and hepatocellular carcinoma.
Topics: Aged; Carcinoma, Hepatocellular; Diabetes Complications; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Granuloma, Plasma Cell; Humans; Kidney Diseases; Liver Neoplasms; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2012 |
Diagnostic value for extrahepatic metastases of hepatocellular carcinoma in positron emission tomography/computed tomography scan.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2012 |
Predictive value of ¹⁸F-fluorodeoxyglucose PET/CT for transarterial chemolipiodolization of hepatocellular carcinoma.
Topics: Aged; alpha-Fetoproteins; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Logistic Models; Male; Middle Aged; Multimodal Imaging; Multivariate Analysis; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Republic of Korea; Retrospective Studies; Risk Assessment; Risk Factors; Survival Analysis; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden | 2012 |
(18)F-FDG-PET/CT predicts early tumor recurrence in living donor liver transplantation for hepatocellular carcinoma.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Liver Transplantation; Living Donors; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2013 |
[A case of hepatocellular carcinoma with multiple lymph node metastases detected by FDG-PET].
Topics: Aged; Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Positron-Emission Tomography; Radiopharmaceuticals | 2012 |
[Value of (18)F-FDG PET/CT and CECT in detecting postoperative recurrence and extrahepatic metastasis of hepatocellular carcinoma in patients with elevated serum alpha-fetoprotein].
Topics: Adult; Aged; Aged, 80 and over; alpha-Fetoproteins; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed | 2012 |
11C-acetate and 18F-FDG PET/CT for clinical staging and selection of patients with hepatocellular carcinoma for liver transplantation on the basis of Milan criteria: surgeon's perspective.
Topics: Adult; Aged; Carbon Radioisotopes; Carcinoma, Hepatocellular; Contrast Media; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Liver Transplantation; Male; Medical Oncology; Middle Aged; Neoplasm Staging; Nuclear Medicine; Positron-Emission Tomography; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2013 |
11C-acetate: a new tracer for the evaluation of hepatocellular carcinoma.
Topics: Acetates; Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carbon Radioisotopes; Carcinoma, Hepatocellular; Cholangiocarcinoma; Colonic Neoplasms; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2003 |
FDG positron emission tomography in the surveillance of hepatic tumors treated with radiofrequency ablation.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Carcinoma, Transitional Cell; Catheter Ablation; Colonic Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Insulinoma; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Pancreatic Neoplasms; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sarcoma; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome; Whole-Body Counting | 2003 |
The role of [18F]fluorodeoxyglucose positron emission tomography imaging in the evaluation of hepatocellular carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Biopsy; Carcinoma, Hepatocellular; Decision Trees; Female; Fluorodeoxyglucose F18; Hepatectomy; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Necrosis; Neoplasm Recurrence, Local; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
A well-differentiated hepatocellular carcinoma detected only by F-18 FDG positron emission tomography.
Topics: Aged; Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 2003 |
Impact of positron emission tomography on strategy in liver resection for primary and secondary liver tumors.
Topics: Adenoma, Liver Cell; Breast Neoplasms; Carcinoma, Hepatocellular; Colorectal Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver Neoplasms; Male; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2004 |
[18F-Fluorodeoxyglucose uptake in hepatocellular carcinoma on positron emission tomography correlates with alpha-fetoprotein].
Topics: alpha-Fetoproteins; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Tomography, Emission-Computed | 2004 |
Molecular imaging of hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Diagnosis, Differential; Fluorodeoxyglucose F18; Gene Expression Profiling; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; RNA, Messenger; Sensitivity and Specificity | 2004 |
18F-FDG PET in the detection of extrahepatic metastases from hepatocellular carcinoma.
Topics: Aged; Bone Neoplasms; Carcinoma, Hepatocellular; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Intestinal Neoplasms; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2004 |
FDG-PET and hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2004 |
[Positron emission tomography with fluorine-18-fluorodeoxyglucose is useful for predicting the prognosis of patients with hepatocellular carcinoma].
Topics: Adult; Aged; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Survival Rate | 2004 |
Biologic correlates of intratumoral heterogeneity in 18F-FDG distribution with regional expression of glucose transporters and hexokinase-II in experimental tumor.
Topics: Animals; Biomarkers, Tumor; Carcinoma, Hepatocellular; Cell Line, Tumor; Fluorodeoxyglucose F18; Gene Expression Profiling; Glucose Transporter Type 1; Glucose Transporter Type 3; Hexokinase; Male; Monosaccharide Transport Proteins; Nerve Tissue Proteins; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Wistar; Statistics as Topic | 2005 |
Selective internal radiation therapy with SIR-Spheres in patients with nonresectable liver tumors.
Topics: Adult; Aged; Angiography; Biomarkers, Tumor; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver; Liver Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neovascularization, Pathologic; Positron-Emission Tomography; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2005 |
Enhanced apoptotic reaction correlates with suppressed tumor glucose utilization after cytotoxic chemotherapy: use of 99mTc-Annexin V, 18F-FDG, and histologic evaluation.
Topics: Animals; Annexin A5; Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cyclophosphamide; Deoxycytidine; Fluorodeoxyglucose F18; Gemcitabine; Glucose; Liver Neoplasms; Male; Metabolic Clearance Rate; Organ Specificity; Organotechnetium Compounds; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Wistar; Statistics as Topic; Tissue Distribution | 2005 |
FDG PET for discrimination between tumor extension and blood thrombus as a cause for portal vein thrombosis in hepatocellular carcinoma: important role in exclusion of transplant candidacy.
Topics: Adult; Budd-Chiari Syndrome; Carcinoma, Hepatocellular; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Liver Transplantation; Male; Patient Selection; Positron-Emission Tomography; Preoperative Care; Prognosis; Radiopharmaceuticals; Thrombosis | 2005 |
Hepatocellular carcinoma tumour thrombus in a re-canalised para-umbilical vein: detection by 18-fluoro-2-deoxyglucose positron emission tomography imaging.
Topics: Carcinoma, Hepatocellular; Catheterization; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Umbilical Veins; Venous Thrombosis | 2005 |
[Evaluating efficacy of transcatheter arterial chemo-embolization combined with radiofrequency ablation on patients with hepatocellular carcinoma by 18FDG-PET/CT].
Topics: Adult; Aged; Carcinoma, Hepatocellular; Catheter Ablation; Chemoembolization, Therapeutic; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed; Treatment Outcome | 2005 |
Different glucose uptake and glycolytic mechanisms between hepatocellular carcinoma and intrahepatic mass-forming cholangiocarcinoma with increased (18)F-FDG uptake.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Cholangiocarcinoma; Fluorodeoxyglucose F18; Glucose; Glycolysis; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Tumor Cells, Cultured | 2005 |
18F-FDG PET for hepatocellular carcinoma presenting with portal vein tumor thrombus.
Topics: Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Portal Vein; Positron-Emission Tomography; Radiopharmaceuticals; Thrombosis | 2005 |
PET/CT in patients with hepatocellular carcinoma using [(18)F]fluorocholine: preliminary comparison with [(18)F]FDG PET/CT.
Topics: Carcinoma, Hepatocellular; Choline; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2006 |
Preoperative positron emission tomography with fluorine-18-fluorodeoxyglucose is predictive of prognosis in patients with hepatocellular carcinoma after resection.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2006 |
Dual-time-point PET/CT to differentiate fluorodeoxyglucose-avid hiatal hernia from mediastinal malignancy.
Topics: Aged; Carcinoma, Hepatocellular; Diagnosis, Differential; Esophageal Diseases; Fluorodeoxyglucose F18; Hernia, Hiatal; Humans; Liver Neoplasms; Male; Mediastinal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2006 |
Clinical value of pre-and postoperative 18F-FDG PET/CT in patients undergoing liver transplantation for hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Neoplasm Recurrence, Local; Perioperative Care; Positron-Emission Tomography; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, Spiral Computed | 2006 |
The role of (18)F-FDG-PET imaging for the selection of liver transplantation candidates among hepatocellular carcinoma patients.
Topics: Adult; Aged; alpha-Fetoproteins; Blood Vessels; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Patient Selection; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Analysis | 2006 |
[Diagnostic accuracy of 18F-FDG positron emission tomography for evaluation of hepatocellular carcinoma].
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2006 |
Fluorine-18 fluorodeoxyglucose positron emission tomography predicts tumor differentiation, P-glycoprotein expression, and outcome after resection in hepatocellular carcinoma.
Topics: Adult; Aged; Aged, 80 and over; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Hepatocellular; Cell Differentiation; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Risk | 2007 |
[Malignant tumor with false negative 18F-FDG PET image].
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Hepatocellular; Carcinoma, Renal Cell; Carcinoma, Signet Ring Cell; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Liver Neoplasms; Male; Middle Aged; Omentum; Peritoneal Neoplasms; Positron-Emission Tomography; Radiographic Image Enhancement; Stomach Neoplasms; Tomography, X-Ray Computed | 2006 |
Dual-tracer PET/CT imaging in evaluation of metastatic hepatocellular carcinoma.
Topics: Acetic Acid; Adolescent; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Carbon Radioisotopes; Carcinoma, Hepatocellular; Evaluation Studies as Topic; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2007 |
Changes in glucose metabolism and gene expression after transfer of anti-angiogenic genes in rat hepatoma.
Topics: Angiogenesis Inhibitors; Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Glucose; Liver Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Rats; Recombinant Proteins | 2007 |
Positron emission tomography/computed tomography with (18)F-fluorodeoxyglucose identifies tumor growth or thrombosis in the portal vein with hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Neoplastic Cells, Circulating; Portal Vein; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Venous Thrombosis | 2007 |
Extensive FDG uptake and its modification with corticosteroid in a granuloma rat model: an experimental study for differentiating granuloma from tumors.
Topics: Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Diagnosis, Differential; Disease Models, Animal; Fluorodeoxyglucose F18; Glucocorticoids; Granuloma; Liver Neoplasms; Male; Metabolic Clearance Rate; Prednisolone; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Wistar | 2007 |
Whole-body F-18 FDG PET for hepatocellular carcinoma patients after interventional treatment.
Topics: Aged; Aged, 80 and over; alpha-Fetoproteins; Carcinoma, Hepatocellular; Catheter Ablation; Ethanol; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2007 |
Positron emission tomography/computer tomography in guidance of extrahepatic hepatocellular carcinoma metastasis management.
Topics: Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiography; Tomography, Emission-Computed | 2007 |
Early diagnosis of recurrent hepatocellular carcinoma with 18F-FDG PET after radiofrequency ablation therapy.
Topics: Aged; Carcinoma, Hepatocellular; Catheter Ablation; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence | 2007 |
FDG PET/CT imaging to rule out extrahepatic metastases before liver transplantation.
Topics: Aged; Biopsy; Carcinoma, Hepatocellular; Contraindications; Diagnosis, Differential; Eligibility Determination; Fluorodeoxyglucose F18; Granuloma, Respiratory Tract; Humans; Immune Tolerance; Liver Neoplasms; Liver Transplantation; Lung Neoplasms; Male; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2007 |
18F-labeled resin microspheres as surrogates for 90Y resin microspheres used in the treatment of hepatic tumors: a radiolabeling and PET validation study.
Topics: Animals; Carcinoma, Hepatocellular; Embolization, Therapeutic; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Microspheres; Positron-Emission Tomography; Rabbits; Radiopharmaceuticals; Radiotherapy Dosage; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Sensitivity and Specificity; Yttrium Radioisotopes | 2007 |
Usefulness of 11C-methionine for differentiating tumors from granulomas in experimental rat models: a comparison with 18F-FDG and 18F-FLT.
Topics: Animals; Carbon Radioisotopes; Carcinoma, Hepatocellular; Cell Line, Tumor; Diagnosis, Differential; Dideoxynucleosides; Fluorodeoxyglucose F18; Granuloma; Inflammation; Liver Neoplasms; Male; Methionine; Mycobacterium bovis; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Turpentine | 2008 |
Role of 18F-fluorodeoxyglucose positron emission tomography in detecting extrahepatic metastasis in pretreatment staging of hepatocellular carcinoma.
Topics: Adult; Aged; Bone Neoplasms; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals | 2007 |
Clinicopathological presentation of varying 18F-FDG uptake and expression of glucose transporter 1 and hexokinase II in cases of hepatocellular carcinoma and cholangiocellular carcinoma.
Topics: Aged; Biomarkers, Tumor; Carcinoma, Hepatocellular; Cholangiocarcinoma; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Hexokinase; Humans; Liver Neoplasms; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals | 2008 |
Highly metabolic thrombus of the portal vein: 18F fluorodeoxyglucose positron emission tomography/computer tomography demonstration and clinical significance in hepatocellular carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Portal Vein; Positron-Emission Tomography; Thrombosis; Tomography, X-Ray Computed | 2008 |
In vivo assessment of glucose metabolism in hepatocellular carcinoma with FDG-PET.
Topics: Carcinoma, Hepatocellular; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Glucose-6-Phosphatase; Hexokinase; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Tomography, Emission-Computed | 1995 |
[Usefulness of 99mTc-PMT SPECT and 18F-FDG PET in diagnosing orbital metastasis of hepatocellular carcinoma].
Topics: Aged; Carcinoma, Hepatocellular; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Orbital Neoplasms; Organotechnetium Compounds; Predictive Value of Tests; Pyridoxal; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Tryptophan | 1994 |
Fluorodeoxyglucose PET of abdominal and pelvic neoplasms: potential role in oncologic imaging.
Topics: Abdominal Neoplasms; Carcinoma, Hepatocellular; Colorectal Neoplasms; Deoxyglucose; Fluorodeoxyglucose F18; Hemangioma, Cavernous; Humans; Liver Neoplasms; Lymphoma, Non-Hodgkin; Pelvic Neoplasms; Tomography, Emission-Computed | 1993 |
[PET studies with C-11 ethanol in intratumoral therapy of hepatocellular carcinomas].
Topics: Aged; Blood Glucose; Brain; Brain Neoplasms; Carbon Radioisotopes; Carcinoma, Hepatocellular; Deoxyglucose; Ethanol; Female; Fluorodeoxyglucose F18; Humans; Injections, Intralesional; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Tomography, Emission-Computed | 1996 |
Hepatocellular carcinoma outcomes based on indicated treatment strategy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Fluorodeoxyglucose F18; Hepatectomy; Humans; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Retrospective Studies; Survival Analysis; Tennessee; Tomography, Emission-Computed; Treatment Outcome | 1998 |
Limited value of fluorine-18-fluorodeoxyglucose PET for the differential diagnosis of focal liver lesions in patients with chronic hepatitis C virus infection.
Topics: Adult; Aged; Biopsy, Needle; Carcinoma, Hepatocellular; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Hepatitis C, Chronic; Humans; Liver Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed; Ultrasonography | 1998 |
Combined hepatocellular carcinoma and cholangiocarcinoma with high F-18 fluorodeoxyglucose positron emission tomographic uptake.
Topics: Adult; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Cholangiocarcinoma; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Liver Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 1999 |
Hepatocellular carcinoma monitored by F-18 fluorodeoxyglucose positron emission tomography after laparoscopic microwave coagulation therapy.
Topics: Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Microwaves; Middle Aged; Tomography, Emission-Computed | 1999 |
Glut-1 and hexokinase expression: relationship with 2-fluoro-2-deoxy-D-glucose uptake in A431 and T47D cells in culture.
Topics: Biological Transport; Breast Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Squamous Cell; Cell Membrane; Colonic Neoplasms; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Enzymologic; Glucose Transporter Type 1; Hexokinase; Humans; Isoenzymes; Kinetics; Liver Neoplasms; Monosaccharide Transport Proteins; Radiopharmaceuticals; RNA, Messenger; Transcription, Genetic; Tumor Cells, Cultured | 1999 |
Fluorine-18 FDG positron emission tomography for imaging of hepatocellular carcinoma.
Topics: Adult; Aged; alpha-Fetoproteins; Carcinoma, Hepatocellular; Contrast Media; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Liver; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed; Tumor Suppressor Protein p53; Ultrasonography; Whole-Body Counting | 1999 |
Dynamic 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography of liver tumours without blood sampling.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Carcinoma; Carcinoma, Hepatocellular; Cholangiocarcinoma; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed | 2000 |
Clinical usefulness of positron emission tomography with fluorine-18-fluorodeoxyglucose in the diagnosis of liver tumors.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Cholangiocarcinoma; Diagnosis, Differential; Fluorodeoxyglucose F18; Focal Nodular Hyperplasia; Hemangioma; Humans; Liver Neoplasms; Middle Aged; Prognosis; Radiopharmaceuticals; Tomography, Emission-Computed | 2000 |
Ga-67-positive and F-18 FDG-negative imaging in well-differentiated hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; False Negative Reactions; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Liver Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2001 |
Physiological FDG uptake in the palatine tonsils.
Topics: Adult; Aged; Biological Transport; Brain Neoplasms; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Palatine Tonsil; Pancreatic Neoplasms; Radiopharmaceuticals; Tissue Distribution; Tomography, Emission-Computed | 2001 |
Fluorine-18 FDG imaging in hepatocellular carcinoma using positron coincidence detection and single photon emission computed tomography.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Pilot Projects; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2002 |
Evaluation of liver tumors using fluorine-18-fluorodeoxyglucose PET: characterization of tumor and assessment of effect of treatment.
Topics: Adenoma, Bile Duct; Carcinoma, Hepatocellular; Deoxyglucose; Fluorodeoxyglucose F18; Hexokinase; Humans; Liver; Liver Neoplasms; Tomography, Emission-Computed | 1992 |
Pattern of 2-deoxy-2-[18F]-fluro-D-glucose accumulation in liver tumours: primary, metastatic and after chemotherapy.
Topics: Adenocarcinoma; Carcinoma, Hepatocellular; Colonic Neoplasms; Deoxyglucose; Fluorodeoxyglucose F18; Fluorouracil; Humans; Interleukin-2; Liver Neoplasms; Recombinant Proteins; Rectal Neoplasms; Tomography, Emission-Computed | 1992 |
[Can fluorodeoxyglucose-positron emission tomography evaluate the functional differentiation of hepatocellular carcinoma].
Topics: Carcinoma, Hepatocellular; Cell Differentiation; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Predictive Value of Tests; Retrospective Studies; Tomography, Emission-Computed | 1991 |
[Diagnosis of liver tumors with 18F-FDG and 18F-FDGal using PET].
Topics: Carcinoma, Hepatocellular; Deoxyglucose; Fluorodeoxyglucose F18; Fucose; Humans; Liver Neoplasms; Tomography, Emission-Computed | 1991 |
Imaging of hepatoma with 18F-fluorodeoxyglucose.
Topics: Carcinoma, Hepatocellular; Deoxy Sugars; Deoxyglucose; Female; Fluorine; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Middle Aged; Radioisotopes; Radionuclide Imaging | 1985 |